<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Neurodev Disord</journal-id>
<journal-id journal-id-type="iso-abbrev">J Neurodev Disord</journal-id>
<journal-title-group>
<journal-title>Journal of Neurodevelopmental Disorders</journal-title>
</journal-title-group>
<issn pub-type="ppub">1866-1947</issn>
<issn pub-type="epub">1866-1955</issn>
<publisher>
<publisher-name>BioMed Central</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32393163</article-id>
<article-id pub-id-type="pmc">7212686</article-id>
<article-id pub-id-type="publisher-id">9317</article-id>
<article-id pub-id-type="doi">10.1186/s11689-020-09317-2</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Transcriptome analysis of neural progenitor cells derived from Lowe syndrome induced pluripotent stem cells: identification of candidate genes for the neurodevelopmental and eye manifestations</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Liu</surname>
<given-names>Hequn</given-names>
</name>
<address>
<email>hequn.liu@einstein.yu.edu</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Barnes</surname>
<given-names>Jesse</given-names>
</name>
<address>
<email>Jbarnes3@mail.einstein.yu.edu</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pedrosa</surname>
<given-names>Erika</given-names>
</name>
<address>
<email>Erika.Pedrosa@einstein.yu.edu</email>
</address>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Herman</surname>
<given-names>Nathaniel S.</given-names>
</name>
<address>
<email>nherman325@gmail.com</email>
</address>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Salas</surname>
<given-names>Franklin</given-names>
</name>
<address>
<email>frsalas@montefiore.org</email>
</address>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Ping</given-names>
</name>
<address>
<email>ping.wang@einstein.yu.edu</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" equal-contrib="yes">
<name>
<surname>Zheng</surname>
<given-names>Deyou</given-names>
</name>
<address>
<email>deyou.zheng@einstein.yu.edu</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff3">3</xref>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Lachman</surname>
<given-names>Herbert M.</given-names>
</name>
<address>
<email>herb.lachman@einstein.yu.edu</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff3">3</xref>
<xref ref-type="aff" rid="Aff5">5</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.251993.5</institution-id><institution-id institution-id-type="ISNI">0000000121791997</institution-id><institution>Department of Genetics, </institution><institution>Albert Einstein College of Medicine, </institution></institution-wrap>Bronx, New York, USA </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.251993.5</institution-id><institution-id institution-id-type="ISNI">0000000121791997</institution-id><institution>Department of Psychiatry and Behavioral Sciences, </institution><institution>Albert Einstein College of Medicine, </institution></institution-wrap>Bronx, New York, USA </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.251993.5</institution-id><institution-id institution-id-type="ISNI">0000000121791997</institution-id><institution>Dominick P Purpura Department of Neuroscience, </institution><institution>Albert Einstein College of Medicine, </institution></institution-wrap>Bronx, New York, USA </aff>
<aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.251993.5</institution-id><institution-id institution-id-type="ISNI">0000000121791997</institution-id><institution>Department of Neurology, </institution><institution>Albert Einstein College of Medicine, </institution></institution-wrap>Bronx, New York, USA </aff>
<aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.251993.5</institution-id><institution-id institution-id-type="ISNI">0000000121791997</institution-id><institution>Department of Medicine, </institution><institution>Albert Einstein College of Medicine, </institution></institution-wrap>Bronx, New York, USA </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>11</day>
<month>5</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>11</day>
<month>5</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="collection">
<year>2020</year>
</pub-date>
<volume>12</volume>
<elocation-id>14</elocation-id>
<history>
<date date-type="received">
<day>16</day>
<month>10</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>28</day>
<month>4</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2020</copyright-statement>
<license license-type="OpenAccess">
<license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<sec>
<title>Background</title>
<p id="Par1">Lowe syndrome (LS) is caused by loss-of-function mutations in the X-linked gene OCRL, which codes for an inositol polyphosphate 5-phosphatase that plays a key role in endosome recycling, clathrin-coated pit formation, and actin polymerization. It is characterized by congenital cataracts, intellectual and developmental disability, and renal proximal tubular dysfunction. Patients are also at high risk for developing glaucoma and seizures. We recently developed induced pluripotent stem cell (iPSC) lines from three patients with LS who have hypomorphic variants affecting the 3′ end of the gene, and their neurotypical brothers to serve as controls.</p>
</sec>
<sec>
<title>Methods</title>
<p id="Par2">In this study, we used RNA sequencing (RNA-seq) to obtain transcriptome profiles in LS and control neural progenitor cells (NPCs).</p>
</sec>
<sec>
<title>Results</title>
<p id="Par3">In a comparison of the patient and control NPCs (<italic>n</italic> = 3), we found 16 differentially expressed genes (DEGs) at the multiple test adjusted <italic>p</italic> value (padj) &lt; 0.1, with nine at padj &lt; 0.05. Using nominal <italic>p</italic> value &lt; 0.05, 319 DEGs were detected. The relatively small number of DEGs could be due to the fact that OCRL is not a transcription factor per se, although it could have secondary effects on gene expression through several different mechanisms. Although the number of DEGs passing multiple test correction was small, those that were found are quite consistent with some of the known molecular effects of OCRL protein, and the clinical manifestations of LS. Furthermore, using gene set enrichment analysis (GSEA), we found that genes increased expression in the patient NPCs showed enrichments of several gene ontology (GO) terms (false discovery rate &lt; 0.25): telencephalon development, pallium development, NPC proliferation, and cortex development, which are consistent with a condition characterized by intellectual disabilities and psychiatric manifestations. In addition, a significant enrichment among the nominal DEGs for genes implicated in autism spectrum disorder (ASD) was found (e.g., AFF2, DNER, DPP6, DPP10, RELN, CACNA1C), as well as several that are strong candidate genes for the development of eye problems found in LS, including glaucoma. The most notable example is EFEMP1, a well-known candidate gene for glaucoma and other eye pathologies.</p>
</sec>
<sec>
<title>Conclusion</title>
<p id="Par4">Overall, the RNA-seq findings present several candidate genes that could help explain the underlying basis for the neurodevelopmental and eye problems seen in boys with LS.</p>
</sec>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>Lowe syndrome</kwd>
<kwd>Dent disease</kwd>
<kwd>EFEMP1</kwd>
<kwd>Glaucoma</kwd>
<kwd>Macular degeneration</kwd>
<kwd>Cataracts</kwd>
<kwd>OCRL</kwd>
<kwd>MEIS2</kwd>
<kwd>TMEM132</kwd>
<kwd>SPON1</kwd>
<kwd>DPP10</kwd>
<kwd>Kv4.2</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution>National Institute of Mental Health (US)</institution>
</funding-source>
<award-id>MH099427</award-id>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000071</institution-id>
<institution>National Institute of Child Health and Human Development</institution>
</institution-wrap>
</funding-source>
<award-id>1P30HD071593</award-id>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100003925</institution-id>
<institution>Lowe Syndrome Association</institution>
</institution-wrap>
</funding-source>
<award-id>N/A</award-id>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2020</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Introduction</title>
<p id="Par22">Lowe syndrome (LS) (OMIM #300535) is a rare genetic disorder (~ 1/500,000 males) caused by mutations in the X-linked gene, <italic>OCRL</italic> (<italic>OCRL</italic>-<italic>1</italic>) [<xref ref-type="bibr" rid="CR1">1</xref>–<xref ref-type="bibr" rid="CR4">4</xref>]. It is characterized by the triad of congenital cataracts, intellectual and developmental disability (IDD), and renal proximal tubular dysfunction [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR5">5</xref>–<xref ref-type="bibr" rid="CR10">10</xref>]. Hypotonia, epilepsy, stereotypical behaviors, and a high rate of glaucoma are also observed.</p>
<p id="Par23"><italic>OCRL</italic> codes for a 901 amino acid protein, inositol polyphosphate 5-phosphatase that plays a key role in endosome trafficking, clathrin-coated pit formation, and actin polymerization, by catalyzing the removal of the 5′ phosphate from phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2), phosphatidylinositol 1,4,5-trisphosphate, and inositol 1,3,4,5-tetrakisphosphate [<xref ref-type="bibr" rid="CR10">10</xref>–<xref ref-type="bibr" rid="CR16">16</xref>].</p>
<p id="Par24">The molecular basis of LS has primarily been studied in fibroblasts derived from patients and immortalized cell lines (e.g., HeLa; Cos-7 cells). These studies show that abnormalities in endosome recycling, in particular, megalin receptor recycling in the proximal tubules, and primary cilia dysfunction in the eye, underlie some of the clinical features [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR17">17</xref>–<xref ref-type="bibr" rid="CR21">21</xref>]. However, the neurodevelopmental and behavioral aspects of LS have not been adequately investigated in human neuronal cells or animal models. A zebrafish <italic>ocrl1</italic> deficiency model has been developed, in which an increase in the susceptibility to heat-induced seizures, cystic brain lesions, and reduced Akt signaling have been observed [<xref ref-type="bibr" rid="CR22">22</xref>]. Unfortunately, <italic>Ocrl</italic> knockout (KO) mice have significant limitations as a model system to study the neurodevelopmental aspect of LS. The original KO mouse is asymptomatic, due to compensation by the <italic>Ocrl</italic> paralog, <italic>Inpp5b</italic>, since a double <italic>Ocrl</italic>/<italic>Inpp5b</italic> KO is embryonic lethal [<xref ref-type="bibr" rid="CR23">23</xref>–<xref ref-type="bibr" rid="CR25">25</xref>]. Recently, a mouse model was developed by expressing the human <italic>INPP5B</italic> gene, which rescues the double KO, embryonic lethal phenotype KO [<xref ref-type="bibr" rid="CR26">26</xref>]. These mice show an endolysosomal deficit in cultured proximal tubule cells. However, learning and behavioral deficits and eye pathologies were not observed.</p>
<p id="Par25">Because of the dearth of neurodevelopmental findings in <italic>Ocrl</italic> KO mice, we developed an induced pluripotent stem cell (iPSC) model from three patients and their typically developing brothers. All three LS subjects have hypomorphic mutations affecting the C-terminal end of the protein [<xref ref-type="bibr" rid="CR27">27</xref>]. We previously showed that neural progenitor cells (NPCs) derived from patient-specific iPSCs are deficient in their capacity to produce filamentous actin fibers (F-actin) and WAVE-1, a component of the WAVE regulatory complex (WRC) that controls actin polymerization [<xref ref-type="bibr" rid="CR27">27</xref>]. The effect of these deficits on neuronal function is currently under investigation.</p>
<p id="Par26">Although our preliminary studies have focused on some of the known effects of OCRL described in non-neuronal cells, we are also interested in identifying molecular and cellular pathways that might be uniquely affected in neural cells. One effective approach to examine molecular disruptions in an unbiased, genome-wide manner is RNA-seq. Our previous RNA-seq studies have resulted in the discoveries of novel pathways involved in <italic>CHD8</italic>-associated autism spectrum disorder (ASD), schizophrenia (SZ) associated with 22q11.2 deletion syndrome, and a mouse model for Rett syndrome [<xref ref-type="bibr" rid="CR28">28</xref>–<xref ref-type="bibr" rid="CR30">30</xref>]. RNA-seq has also been used successfully by other groups to identify pathways of interest in neuropsychiatric and neurodevelopmental disorders [<xref ref-type="bibr" rid="CR31">31</xref>–<xref ref-type="bibr" rid="CR35">35</xref>].</p>
<p id="Par27">Consequently, RNA-seq was used to screen NPCs derived from LS-specific iPSCs and controls; their typically developing brothers. At the significant level of nominal <italic>p</italic> value &lt; 0.05, 319 differentially expressed genes (DEGs) were found. Among them, 16 remained statistically significant after multiple test correction at the adjusted <italic>p</italic> (padj) &lt; 0.1, and nine at the padj &lt; 0.05. However, among these, there were several strong candidates for the eye and behavioral/neurological pathologies seen in LS; most notably, <italic>EFEMP1</italic>, <italic>DPP10</italic>, and <italic>SPON1</italic>.</p>
</sec>
<sec id="Sec2">
<title>Methods</title>
<sec id="Sec3">
<title>Subjects</title>
<p id="Par28">The study and consent forms were approved by the Albert Einstein College of Medicine (AECOM) internal review board (IRB). A diagnosis of LS was made during infancy in each patient based on clinical findings (congenital cataracts, hypotonia), fibroblast OCRL enzyme activity, and ultimately by genotyping. The patients (LS100, LS300, LS500) harbor mutations in the 3′ end of the gene that codes for the ASH-RhoGap domain (Table <xref ref-type="table" rid="Tab1">1</xref>). A detailed molecular genetic analysis of the effects of these mutations on splicing can be found in our previous publication [<xref ref-type="bibr" rid="CR27">27</xref>]. Their neurotypically developing brothers (LS200, LS400, and LS600, respectively) served as controls. All subjects were between 11 and 25 years of age when recruited, and the sibling pairs were 2–4 years apart in age.
<table-wrap id="Tab1"><label>Table 1</label><caption><p><italic>OCRL</italic> mutations in patients</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Patient</th><th>Exon/intron</th><th>Mutation</th><th>Genomic position (hg19)</th><th>Type</th></tr></thead><tbody><tr><td>LS100</td><td>Intron 23</td><td>c.2582-1 G&gt;T</td><td>chrX:128724122</td><td>Splice acceptor</td></tr><tr><td>LS300</td><td>Intron 22</td><td>c.2470-2 A&gt;G</td><td>chrX:128723820</td><td>Splice acceptor</td></tr><tr><td>LS500</td><td>Exon 20</td><td>c.2179delC</td><td>chrX:128721069</td><td>Del/frame shift</td></tr></tbody></table></table-wrap></p>
</sec>
<sec id="Sec4">
<title>Development of iPSCs cells from peripheral blood CD34<sup>+</sup> cells</title>
<p id="Par29">iPSC lines were generated from human peripheral blood CD34<sup>+</sup> cells with a CytoTune-iPS 2.0 Sendai Reprogramming Kit (Invitrogen) as previously described [<xref ref-type="bibr" rid="CR36">36</xref>]. The growth and maintenance of the iPSCs used in this study are described in our recent publication [<xref ref-type="bibr" rid="CR27">27</xref>].</p>
</sec>
<sec id="Sec5">
<title>Generating neural progenitor cells from iPSCs using dual SMAD inhibition</title>
<p id="Par30">A monolayer neural progenitor cell (NPC) culture protocol was adapted from the STEMCELL Technologies STEMdiff<sup>TM</sup> SMADi Neural Induction Kit with slight modifications. Briefly, iPSCs were maintained in mTeSR1 with daily feeding until cells reached the point of passaging. At the start of induction, differentiated cells, if present, were manually removed and the iPSCs were washed with PBS. Gentle dissociation reagent (STEMCELL Tech) was added for 8–10 min at 37 °C. Cells were dislodged by pipetting with a sterile 1 ml pipet tip and collected in a 15 ml tube. Cell culture plates were rinsed with DMEM/F12 and added to the tube containing the cell suspension. Viable cells were counted with a hemocytometer using the Trypan Blue exclusion method. Cells were then centrifuged at 300×<italic>g</italic> for 5 min. Supernatant was carefully aspirated and the cell pellet was re-suspended in STEMdiff<sup>TM</sup> SMADi Neural Induction Medium + 10 μM Y-27632 to obtain a final concentration of 10<sup>6</sup> cell/ml. Two milliliters of cell suspension were aliquoted to one well of a 6-well plate that was pre-coated with matrigel. This was designated as passage 0 (P0). Cells were allowed to grow with daily feeding for 6 days in STEMdiff SMADi Neural Induction medium. Note that Y-27632 is not required for the daily medium changes. NPCs were ready for passage when cultures were approximately 90% confluent (6 days). For passaging, NPCs were washed with DMEM/F12 and 1 ml of accutase was added to each well for 5 min at 37 °C. Cells were dislodged with a sterile 1 ml pipet tip and collected in a 15 ml tube containing DMEM/F12. Viable cells were counted using Trypan Blue exclusion. Cells were then centrifuged at 300×<italic>g</italic> for 5 min. Supernatant was carefully aspirated and the cell pellet was re-suspended in STEMdiff<sup>TM</sup> SMADi Neural Induction Medium + 10 μM Y-27632. Cells were plated at a density of 1.5 × 10<sup>6</sup> live cells/well in a 6-well plate pre-coated with PORN/Laminin. NPCs were fed daily, without Y-27632m, and were ready for downstream applications at passage 3. At this stage, none of the cells stained for the stem cell marker, OCT4 (POU5F1) and virtually 100% were positive for the NPC markers vimentin and SOX2 (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S1). Furthermore, we compared our NPC RNA-seq data with gene expression in multiple neural and non-neural cell lines (or tissues) analyzed by RNA-seq in the ENCODE project [<xref ref-type="bibr" rid="CR37">37</xref>] and found that the most correlated cell line was neural progenitor cell (ENCFF663ARH, Pearson’s correlation coefficients (<italic>r</italic>) = 0.88) (Additional file <xref ref-type="media" rid="MOESM2">2</xref>: Figure S2).</p>
</sec>
<sec id="Sec6">
<title>RNA-seq</title>
<p id="Par31">Total cellular RNA was extracted using the miRNeasy Mini Kit (QIAGEN, catalogue# 217004) according to the manufacturer’s instructions (QIAGEN). An additional treatment with DNase I (QIAGEN, Valencia, CA) was included to remove genomic DNA. After passing quality control, high throughput sequencing libraries were prepared by Novogene, and 150 bp paired-end RNA-seq reads were obtained. RNA-seq reads were aligned to the human reference genome (hg19) by the software HISAT2 (v2.0.4) [<xref ref-type="bibr" rid="CR38">38</xref>]. HTseq (v0.11.0) [<xref ref-type="bibr" rid="CR39">39</xref>] was used to determine the read counts while the StringTie (v1.2.2) [<xref ref-type="bibr" rid="CR40">40</xref>] was used to compute fragments per kilobase of exon per million fragments mapped (FPKM) and transcript per million (TPM) for each of the genes annotated in the GENCODE database (v29) [<xref ref-type="bibr" rid="CR41">41</xref>], including protein-coding, non-coding, and all other transcript types. Genes with TPM &gt; 1 in at least one of the 12 samples were used for downstream analysis. RNA-seq read counts of the two biological replicates (A/B) were merged using the “collapseReplicates” function in the software DESeq2 [<xref ref-type="bibr" rid="CR42">42</xref>], resulting in three samples each for the patient and control NPCs for differential expression analysis genes by DESeq2. The overlap of DEGs with various disease gene lists was evaluated for statistical significance by Fisher’s test. We also performed gene set enrichment analysis (GSEA; v4.0.1), using the gene sets in the gene ontology (GO) “Biological Process” category and ranking genes (<italic>n</italic> = 20,728) by fold changes (“log2_Ratio_of_Classes”), and otherwise default parameters.</p>
</sec>
<sec id="Sec7">
<title>Quantitative real time PCR</title>
<p id="Par32">Quantitative real-time PCR (qPCR) was carried out on reverse-transcribed PCR using the 2<sup>-ΔΔCt</sup> method as we previously described [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR43">43</xref>].</p>
</sec>
<sec id="Sec8">
<title>Immunocytochemistry</title>
<p id="Par33">Immunocytochemistry (ICC) was carried out as previously described [<xref ref-type="bibr" rid="CR27">27</xref>] using mouse anti-Vimentin (Invitrogen cat#18-0052) at a 1:100 dilution, and Anti-Sox2 (StemCell Technologies cat#60055.1) at a 1:50 dilution.</p>
</sec>
<sec id="Sec9">
<title>Western blotting</title>
<p id="Par34">Proteins were prepared with ProteoExtract Complete Mammalian Proteome Extraction Kit (Millipore cat# 539779) according to the manufacturer’s protocol. Protein concentrations were verified using the Bradford method. Briefly, 30–60 μg of protein were denatured with the addition of Laemmli buffer and 2-mercaptoethanol, and boiled for 5 min. Samples were loaded onto a 12% precast polyacrylamide gel (BIO-RAD cat#456-1044). Gel electrophoresis was set at constant voltage (50 V) for the first 30 min and 120 V for the remainder of the run. The running buffer was in 1× TrisGlycine/SDS buffer. After separation by electrophoresis, proteins were transferred using the Trans-Blot® TurboTM Transfer System according to the manufacturer’s instructions. A 7-min transfer was executed using the turbo program setting. After transfer, membranes were blocked in 5% milk with gentle agitation for 1 h at room temperature. Membranes were then incubated overnight with gentle agitation at 4 °C with primary antibodies for 48 h (Anti-OCRL; Proteintech Group, catalog# 17695-1-AP, 1:500 dilution: Anti-GAPDH; ThermoFisher Scientific, catalog# MA5-15738, 1:2,000 dilution). Following primary antibody incubation, membranes were washed three times with gentle agitation in 1× TBS/T buffer (20 mM Tris Base, 0.136 M NaCl, 0.1% Tween-20). Membranes were then incubated with a secondary antibody (1:5,000 dilution) plus anti-biotin (1:2,000 dilution) for 1 h at room temperature with gentle agitation. Membranes were washed again, as above, and subsequently incubated with SuperSignal<sup>TM</sup> West Dura Extended Duration Substrate (Thermo Scientific cat# 34075) for 5 min at room temperature with gentle agitation. Immediately thereafter, membranes were exposed to blue autoradiograph film for visualization. For quantification, autoradiograms were scanned and the protein of interest was normalized against a control protein, GAPDH</p>
</sec>
<sec id="Sec10">
<title>OCRL knockdown</title>
<p id="Par35">An immortalized human retinal pigmented epithelium cell line, RPE-1 (ATCC® Number: CRL-4000), was used for OCRL knockdown (KD) experiments. These were carried out with Dharmacon™ siGENOME Human OCRL siRNA (cat# D-010026-01-0005, Horizon Discovery) and were transfected into RPE cells using DharmaFECT 1 Transfection reagent (Horizon Discovery) in DMEM medium containing 10% FBS without antibiotics. siGENOME non-targeting siRNA #3 (cat#D-001210-03-05, Horizon Discovery) was used as a control. siRNAs were transfected into RPE-1 cells at a concentration of 25 nM for 72 h according to the manufacturer’s protocol.</p>
</sec>
<sec id="Sec11">
<title>PCR primers used in this study</title>
<p id="Par36">
<table-wrap id="Taba"><table frame="hsides" rules="groups"><tbody><tr><td>Gene</td><td>Left</td><td>Right</td></tr><tr><td>β2M</td><td>gctcgcgctactctctcttt</td><td>caatgtcggatggatgaaac</td></tr><tr><td>OCRL_LS500</td><td>cctgcatgaccagaatttga</td><td>ttaaaagcgctatgctgacg</td></tr><tr><td>OCRLexp-F</td><td>acaggtcctgcttcccacta</td><td>tggaggtggatgtctaggca</td></tr><tr><td>OCRLexp2-F</td><td>atccacctccagagcaacac</td><td>gctgtgggaaggagcaatag</td></tr><tr><td>OCRL_KO</td><td>agagctgccctcatttcctt</td><td>tgggcctggacttgataaaa</td></tr><tr><td>LS100cDNA</td><td>ttttcttggaagccctgcca</td><td>tgccataaggttgggtggag</td></tr><tr><td>LS300cDNA</td><td>agcgtcaatgccaacatgatc</td><td>aaggagggattaggaaacgctc</td></tr><tr><td>OCRL_LS100/300</td><td>attgtgttggccatgaggag</td><td>ggaggcctcaggagaagact</td></tr></tbody></table></table-wrap>
</p>
</sec>
<sec id="Sec12">
<title>Sequencing primers</title>
<p id="Par37">
<table-wrap id="Tabb"><table frame="hsides" rules="groups"><tbody><tr><td>LS100seq</td><td>aatactcttagtgcattgtatc</td></tr><tr><td>LS300seq</td><td>tagaagttagacagatgaaatg</td></tr><tr><td>LS500</td><td>cctgcatgaccagaatttga</td></tr></tbody></table></table-wrap>
</p>
</sec>
<sec id="Sec13">
<title>qPCR primers</title>
<p id="Par38">
<table-wrap id="Tabc"><table frame="hsides" rules="groups"><tbody><tr><td>TMEM132C</td><td>cacctctatggcagctctcc</td><td>cccgactgttcttcaccact</td></tr><tr><td>TMEM132D</td><td>gaatcctgccagaaatccaa</td><td>gtgttggggttagcatcgtt</td></tr><tr><td>INPP5F</td><td>tagcgttcatgctccttcag</td><td>atatgtgtacgtcgccagca</td></tr><tr><td>MEIS2</td><td>ccaggggactacgtttctca</td><td>tgagtagggtgtggggtcat</td></tr><tr><td>SLC1A3a</td><td>gccttgagcaagtcccatct</td><td>caggatgtctgggctggaag</td></tr><tr><td>ADCY2</td><td>gtgcgtgctgtctgtcctat</td><td>acgatctgggcacacatcag</td></tr><tr><td>TMEM47</td><td>tcctttgcgctgacaaggat</td><td>tcaagggctcactcaagcaa</td></tr><tr><td>EFEMP1</td><td>aagtgcaatgcttgtgctcg</td><td>gcggaaggtccctatactgc</td></tr><tr><td>RPLPO</td><td>ccaccacagctgctcctg</td><td>ggctaagttggttgctttttgg</td></tr><tr><td>DPP10</td><td>gtgtttcgctgcacctatga</td><td>agggagggaacaacacacac</td></tr><tr><td>SPON1</td><td>aggagtagtgtcagccacct</td><td>atggttgcctctccatgtgg</td></tr><tr><td>NLRP2</td><td>atgctagactgggcagagga</td><td>cagtccctgaagaccagctc</td></tr><tr><td>CALB1</td><td>tatccaggatgtgtggctca</td><td>tgggtgtactgactggccta</td></tr></tbody></table></table-wrap>
</p>
</sec>
</sec>
<sec id="Sec14">
<title>Results</title>
<sec id="Sec15">
<title>RNA-seq and bioinformatics</title>
<p id="Par39">iPSCs from three subjects with LS and controls were differentiated into NPCs. RNA was extracted and analyzed by paired-end RNA-seq. Two independent NPC samples differentiated from each iPSC line were prepared for duplicated RNA libraries sent for RNA-seq, resulting in a total of 12 biological samples. The overall quality of the RNA-seq reads and alignment was excellent, with a range of 22,150,351–29,297,502 reads, and alignment rates from 85.58 to 90.67% (Additional file <xref ref-type="media" rid="MOESM3">3</xref>: Table S1). In addition, we were able to confirm the mutant <italic>OCRL</italic> genotype for each patient sample in the RNA-seq reads: loss of intron 23/exon 24 splice site with cryptic splice site in exon 24 (LS100); loss of intron 22/exon 23 splice site with absence of exon 23 in the final transcript (LS300); and a “C” del in exon 20 (LS500) (Table <xref ref-type="table" rid="Tab1">1</xref>; Additional file <xref ref-type="media" rid="MOESM4">4</xref>: Figure S3A-C).</p>
<p id="Par40">Since the gene expression profiles of the two duplicated samples were highly correlated, we merged them for determining DEGs in NPCs comparing LS samples and their sibling controls (<italic>n</italic> = 3) using the software DESeq2 [<xref ref-type="bibr" rid="CR42">42</xref>]. At a nominally significant level (<italic>p</italic> &lt; 0.05), 319 DEGs were found (164 genes expressed at higher levels in LS; 155 lower) (Additional file <xref ref-type="media" rid="MOESM5">5</xref>: Table S2). At the multiple test adjusted <italic>p</italic> value (padj) &lt; 0.05, we found nine DEGs (<italic>PCDHB5</italic>, <italic>BARHL1</italic>, <italic>NLRP2</italic>, <italic>EFEMP1</italic>, <italic>SPON1</italic>, <italic>GDA</italic>, <italic>CALB1</italic>, <italic>ZNF736</italic>, <italic>PITX2</italic>), with an additional seven at padj between 0.05 and 0.1 (<italic>INPP5F</italic>, <italic>PEG3</italic>, <italic>SPINK5</italic>, <italic>DPP10</italic>, <italic>MAFB</italic>, <italic>OTP</italic>, <italic>TMEM132C</italic>) (Fig <xref ref-type="fig" rid="Fig1">1</xref>a). Of the 16 DEGs that achieved padj &lt; 0.1, five are known SZ, ASD, IDD or eye disorder candidate genes (<italic>DPP10</italic>, <italic>GDA</italic>, <italic>PITX2</italic>, <italic>EFEMP1</italic>, <italic>SPON1</italic>) (Table <xref ref-type="table" rid="Tab2">2</xref>).
<fig id="Fig1"><label>Fig. 1</label><caption><p><bold>a</bold> Volcano plot showing differentially expressed genes (DEGs) at padj &lt; 0.1; lower expression in LS NPCs compared with controls (green); higher expression (red). <bold>b</bold> Gene ontology terms enriched in genes that are up-regulated in LS NPCs, as determined by gene set enrichment analysis. The size of the circles corresponds to the number of DEGs in a GO term, and the color intensity corresponds to the –log10 (FDR) of enrichment significance. Plots are all GO terms with FDR &lt; 25%</p></caption><graphic id="MO1" xlink:href="11689_2020_9317_Fig1_HTML"></graphic></fig><table-wrap id="Tab2"><label>Table 2</label><caption><p>Genes involved in ASD, SZ, ID, and eye disorders that overlap with the 319 nominal DEGs. Two additional genes were included based on literature support: <italic>MEIS1</italic> is a glaucoma candidate that is not in the NEI/NIH eye database, and <italic>SPON1</italic> is not in any of the SZ candidate gene databases, but was recently identified in an exome sequencing study (both denoted by asterisk *). Genes shown in bold type are the DEGs at padj &lt; 0.1</p></caption><table frame="hsides" rules="groups"><thead><tr><th>ASD</th><th>SZ</th><th>IDD</th><th>EYE</th></tr></thead><tbody><tr><td><italic>AFF2</italic></td><td><italic>BMP6</italic></td><td><italic>AFF2</italic></td><td><italic>CNGB1</italic></td></tr><tr><td><italic>ANO5</italic></td><td><italic>CA8</italic></td><td><italic>CA8</italic></td><td><italic>COL2A1</italic></td></tr><tr><td><italic>CA8</italic></td><td><italic>CACNA1C</italic></td><td><italic>EEF1A2</italic></td><td><bold><italic>EFEMP1</italic></bold></td></tr><tr><td><italic>CACNA1C</italic></td><td><italic>CHN2</italic></td><td><italic>MLC1</italic></td><td><italic>MEIS2*</italic></td></tr><tr><td><italic>CADPS2</italic></td><td><italic>CHRFAM7A</italic></td><td><italic>RELN</italic></td><td><bold><italic>PITX2</italic></bold></td></tr><tr><td><italic>COMT</italic></td><td><italic>COMT</italic></td><td><italic>TH</italic></td><td><bold><italic>SPON1*</italic></bold></td></tr><tr><td><italic>DNAH3</italic></td><td><italic>MLC1</italic></td><td><italic>XYLT1</italic></td><td><italic>TNFRSF11B</italic></td></tr><tr><td><italic>DNER</italic></td><td><italic>PCDHA6</italic></td><td></td><td></td></tr><tr><td><bold><italic>DPP10</italic></bold></td><td><italic>PNPO</italic></td><td></td><td></td></tr><tr><td><italic>DPP6</italic></td><td><italic>PPP1R16B</italic></td><td></td><td></td></tr><tr><td><italic>EEF1A2</italic></td><td><italic>PROZ</italic></td><td></td><td></td></tr><tr><td><italic>GABRG3</italic></td><td><italic>RELN</italic></td><td></td><td></td></tr><tr><td><italic>GALNT10</italic></td><td><italic>SLC1A3</italic></td><td></td><td></td></tr><tr><td><bold><italic>GDA</italic></bold></td><td><italic>SNCG</italic></td><td></td><td></td></tr><tr><td><italic>KCND3</italic></td><td><bold><italic>SPON1*</italic></bold></td><td></td><td></td></tr><tr><td><italic>KCNJ12</italic></td><td><italic>TH</italic></td><td></td><td></td></tr><tr><td><italic>MEIS2</italic></td><td><italic>ADCY2</italic></td><td></td><td></td></tr><tr><td><italic>OTX1</italic></td><td></td><td></td><td></td></tr><tr><td><italic>PCDHA6</italic></td><td></td><td></td><td></td></tr><tr><td>RELN</td><td></td><td></td><td></td></tr><tr><td>RORA</td><td></td><td></td><td></td></tr><tr><td>SYT17</td><td></td><td></td><td></td></tr><tr><td>ZNF385B</td><td></td><td></td><td></td></tr></tbody></table></table-wrap></p>
<p id="Par41">To address the potential limitation in using thresholds for selecting DEGs, we also applied the software GSEA to find enriched GO terms [<xref ref-type="bibr" rid="CR44">44</xref>, <xref ref-type="bibr" rid="CR45">45</xref>]. For genes expressed higher in patient NPCs, 32 “Biological Process”-related GO terms were enriched at false discovery rate (FDR) &lt; 25% (Fig. <xref ref-type="fig" rid="Fig1">1</xref>b). The top GO terms for LS upregulated genes were telencephalon development, pallium development, NPC proliferation, and cortex development, which are consistent with a condition characterized by intellectual disabilities and psychiatric manifestations. For genes showing decreased expression in LS NPCs (an increase in controls), no GO terms passed the 25% FDR threshold. At a nominal <italic>p</italic> value &lt; 0.01, the top terms were vasculature development, nuclear-transcribed mRNA catabolic process, and protein kinase B signaling (Additional file <xref ref-type="media" rid="MOESM6">6</xref>: Figure S4).</p>
<p id="Par42">Finally, we analyzed the overlap of the 319 nominal DEGs with lists of genes that were associated with ASD, schizophrenia (SZ), IDD, and eye diseases in previous studies [<xref ref-type="bibr" rid="CR46">46</xref>–<xref ref-type="bibr" rid="CR53">53</xref>] (SFARI [<ext-link ext-link-type="uri" xlink:href="https://gene.sfari.org/autdb/GS_Home.do">https://gene.sfari.org/autdb/GS_Home.do</ext-link>]; <ext-link ext-link-type="uri" xlink:href="https://neibank.nei.nih.gov/cgi-bin/eyeDiseaseGenes.cgi">https://neibank.nei.nih.gov/cgi-bin/eyeDiseaseGenes.cgi</ext-link>) (Additional file <xref ref-type="media" rid="MOESM7">7</xref>: Table S3). We found that ASD-related genes showed a significant overlap with our DEGs (Fig. <xref ref-type="fig" rid="Fig2">2</xref>). Among the more interesting DEGs in the context of behavioral and cognitive problems are <italic>AFF2</italic>, <italic>ADCY2</italic>, <italic>DNER</italic>, <italic>DPP10</italic>, <italic>CACNA1C</italic>, <italic>MEIS2</italic>, <italic>GDA</italic>, <italic>RELN</italic>, which have been linked to neurodevelopmental disorders and neuropsychiatric disorders in multiple studies (Table <xref ref-type="table" rid="Tab2">2</xref>) [<xref ref-type="bibr" rid="CR54">54</xref>–<xref ref-type="bibr" rid="CR81">81</xref>]. There was also overlap for genes involved in intellectual disabilities, including <italic>AFF2</italic>, <italic>AIFM1</italic>, <italic>CA8</italic>, <italic>EEF1A2</italic>, <italic>MLC1</italic>, and <italic>XYLT1</italic> [<xref ref-type="bibr" rid="CR82">82</xref>–<xref ref-type="bibr" rid="CR87">87</xref>], but statistically the overlap is not significant.
<fig id="Fig2"><label>Fig. 2</label><caption><p>Overlap of 319 nominal DEGs with genes implicated in autism spectrum disorders (ASD), schizophrenia (SZ), intellectual disability (ID), and eye disease. See main text for references and web sites. The size of the circles corresponds to the number of DEGs that overlap with disease-associated genes in the various data sets, while the color intensity corresponds to the –log10 (<italic>p</italic> value) from Fisher’s test. The <italic>n</italic> is the number of genes expressed in our NPC samples; OR is odds ratio; * denotes <italic>p</italic> &lt; 0.05</p></caption><graphic id="MO2" xlink:href="11689_2020_9317_Fig2_HTML"></graphic></fig></p>
<p id="Par43">Interestingly, some enrichment (OR = 1.45; Fig. <xref ref-type="fig" rid="Fig2">2</xref>) was also seen for DEGs involved in eye disorders, consistent with the clinical problems seen in LS. One such gene is <italic>EFEMP1</italic> (EGF containing fibulin extracellular matrix protein 1), which was the most significantly upregulated DEG in our study. <italic>EFEMP1</italic> has been implicated in glaucoma in several genome-wide association studies (GWAS), macular degeneration, age-related macular dystrophy, and Doyne honeycomb retinal dystrophy [<xref ref-type="bibr" rid="CR88">88</xref>–<xref ref-type="bibr" rid="CR94">94</xref>]. <italic>EFEMP1</italic> has also been found to be associated with suicidal behavior in genetic and molecular studies [<xref ref-type="bibr" rid="CR95">95</xref>–<xref ref-type="bibr" rid="CR98">98</xref>].</p>
<p id="Par44">Two other DEGs that are involved in both neurodevelopmental and eye pathologies are <italic>MEIS2</italic> and <italic>SPON1</italic>. <italic>MEIS2</italic> codes for a homeobox protein, and is a key regulator of trabecular meshwork, lens, and retina development [<xref ref-type="bibr" rid="CR99">99</xref>–<xref ref-type="bibr" rid="CR102">102</xref>]. It was also identified as a risk factor in an open-angle glaucoma GWAS [<xref ref-type="bibr" rid="CR103">103</xref>], and <italic>MEIS2</italic> missense mutations and microdeletions have been found in patients with ASD and developmental delay [<xref ref-type="bibr" rid="CR60">60</xref>–<xref ref-type="bibr" rid="CR62">62</xref>, <xref ref-type="bibr" rid="CR81">81</xref>, <xref ref-type="bibr" rid="CR104">104</xref>].</p>
<p id="Par45"><italic>SPON1</italic> codes for SPONDIN-1, an extracellular matrix component involved in axon guidance. Mutations have been found in a SZ exome sequencing study, and genome-wide association studies have implicated the gene in the rate of cognitive decline and dementia severity in Alzheimer disease [<xref ref-type="bibr" rid="CR105">105</xref>–<xref ref-type="bibr" rid="CR108">108</xref>]. It is also a differentially expressed protein in the development of cataracts, and is a major target of the Pax6 pathway during lens development [<xref ref-type="bibr" rid="CR109">109</xref>].</p>
<p id="Par46">We validated six DEGs by qPCR that were significant at padj &lt; 0.1 (<italic>EFEMP1</italic>, <italic>TMEM132C</italic>, <italic>INPP5F</italic>, <italic>DPP10</italic>, <italic>SPON1</italic>, <italic>CALB1</italic>), as well as six others that were nominally significant (<italic>p</italic> &lt; 0.05), which showed significant differences that were in agreement with the RNA-seq data, with the exception of CALB1. This showed the expected decrease, but only a trend toward statistical significance was found (<italic>p</italic> &lt; 0.08) (Fig. <xref ref-type="fig" rid="Fig3">3</xref>). The analysis was carried out on the two original RNA samples sent for sequencing and an independent set of NPCs.
<fig id="Fig3"><label>Fig. 3</label><caption><p>Quantitative real time PCR (qPCR). Selected up and down-regulated genes were analyzed by reverse transcribed PCR using the 2<sup>-ΔΔCt</sup> method with <italic>RPLPO</italic> as a control gene. The <italic>y</italic>-axis is the relative expression compared with a common control RNA. Asterisk(s) (*) and (**) denote <italic>p</italic> &lt; 0.05 and <italic>p</italic> &lt; 0.01 (two-tailed student’s <italic>t</italic> test). The RNA samples were the same ones used in the RNA-seq analysis, combined with a third set of RNAs not used in the RNA-seq experiment. Each sample was analyzed by qPCR twice</p></caption><graphic id="MO3" xlink:href="11689_2020_9317_Fig3_HTML"></graphic></fig></p>
<p id="Par47">These findings suggest that the neurodevelopmental features and eye pathologies seen in LS are mediated, in part, by altered expression of the DEGs we identified.</p>
</sec>
<sec id="Sec16">
<title>OCRL KD in RPE-1 cells</title>
<p id="Par48">To further validate the connection between OCRL expression and genes involved in eye pathology, we knocked down OCRL expression in a human retinal pigmented epithelial cell line, RPE-1. An R345W mutation in <italic>EFEMP1</italic> causes Doyne honeycomb retinal dystrophy [<xref ref-type="bibr" rid="CR92">92</xref>], which leads to activation of the alternative complement pathway in RPE cells [<xref ref-type="bibr" rid="CR110">110</xref>]. RPE-1 cells were transfected with siRNAs targeting <italic>OCRL</italic> mRNA, and a scrambled control. As seen in Fig. <xref ref-type="fig" rid="Fig4">4</xref>, significant decrease in OCRL protein (left panel), and <italic>OCRL</italic> mRNA (right panel) occurred in cells treated with <italic>OCRL</italic> siRNA compared with cells treated with the scrambled control siRNA (83% decrease in normalized OCRL protein, <italic>p</italic> = 0.02; 70% decrease in normalized <italic>OCRL</italic> mRNA, <italic>p</italic> = 3.1E-07, Student’s <italic>t</italic> test, two-tailed). This was accompanied by extremely large increases in the expression of <italic>MEIS2</italic>, which is a regulator of retinal development, as noted above, and <italic>EFEMP1</italic> mRNA (<italic>p</italic> = 0.04 and 0.03, respectively, Student’s <italic>t</italic> test, two-tailed). The relatively modest levels of statistical significance compared with large fold changes are due to the small sample size (two independent KD experiments; qPCR carried out in duplicate).
<fig id="Fig4"><label>Fig. 4</label><caption><p>OCRL knockdown. Left panel shows a western blot of OCRL along with a control protein, GAPDH, after NPCs were exposed to an OCRL siRNA and a scrambled control. Two independent KD experiments were carried out. The right three panels are qPCR results for <italic>OCRL, MEIS2</italic> and <italic>EFEMP1</italic> carried out on two independent RNA samples, both analyzed in duplicate, as described in the methods section an in the Fig. <xref ref-type="fig" rid="Fig3">3</xref> legend</p></caption><graphic id="MO4" xlink:href="11689_2020_9317_Fig4_HTML"></graphic></fig></p>
<p id="Par49">These findings show that the increase in expression of these genes seen in LS NPCs is directly related to the loss of function, patient-specific <italic>OCRL</italic> mutations found in our subjects.</p>
</sec>
</sec>
<sec id="Sec17">
<title>Discussion</title>
<p id="Par50">Overall, the transcriptome findings were relatively modest with respect to the number of DEGs found in all three LS/control pairs compared to differences found between patients and controls in other iPSC disease-model systems that we have analyzed. For example, transcriptome analyses on NPCs, monolayer neurons, and cerebral organoids derived from <italic>CHD8</italic> haploinsufficient iPSC lines resulted in hundreds of shared DEGs with highly significant enrichment of pathways relevant to ASD pathogenesis [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR30">30</xref>]. This could reflect the biological function of the underlying candidate genes. <italic>CHD8</italic> codes for a member of the CHD family of ATP-dependent chromatin-remodeling factors, so major changes in gene expression through both direct and indirect effects on target genes are expected from its haploinsufficiency. By contrast, all of the functions so far attributed to OCRL in non-neuronal cells occur at the post-translational level. As such, many of our observed DEGs could be due to secondary effects through a variety of potential OCRL-affected pathways, such as altered recycling of growth factor receptors linked to activation of transcription factors, and increases in membrane-associated phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2), which can potentially affect protein kinase C-mediated gene expression. Interestingly, a transcription factor binding motif analysis of the promoters of the 319 DEGs found a nominally significant enrichment of a PITX2 motif (<italic>p</italic> &lt; 0.05, vs. all promoters). The expression of <italic>PITX2</italic>, which is important for the development of the anterior chamber of the eye and is a glaucoma candidate gene [<xref ref-type="bibr" rid="CR111">111</xref>–<xref ref-type="bibr" rid="CR113">113</xref>], was significantly reduced in the LS NPCs (Additional file <xref ref-type="media" rid="MOESM5">5</xref>: Table S2).</p>
<p id="Par51">Another factor that could have limited the full potential of RNA-seq to help understand disease pathogenesis in our study is that NPCs derived from iPSCs are grown in vitro under very specific conditions, as opposed to NPCs and other neuronal cells derived from a developing brain where the full repertoire of growth factors and cell-cell interactions that might affect NPC differentiation and gene expression potentially influenced by <italic>OCRL</italic> could come into play. Testing this hypothesis in mammalian brains will have to await the development of a suitable mouse model that recapitulates the neurodevelopmental features of LS.</p>
<p id="Par52">Finally, the number of DEGs might have been reduced because of differences in <italic>OCRL</italic> expression in the three LS NPC samples. Although all three patients have mutations in the ASH-RhoGAP binding domains that generally produce hypomorphic variants, expression of LS500 is substantially lower than his brother and the other LS/control samples (Additional file <xref ref-type="media" rid="MOESM5">5</xref>: Table S2). This was confirmed by qPCR (Fig. <xref ref-type="fig" rid="Fig5">5</xref>, top panel). The decrease in <italic>OCRL</italic> mRNA in LS500 is most likely due to nonsense-mediated decay, and is accompanied by a marked decrease in OCRL protein (Fig. <xref ref-type="fig" rid="Fig5">5</xref>, bottom panel). These observations suggest that producing a truncated, dysfunctional OCRL protein may have additional effects on gene expression and other phenotypes compared with a simple reduction in OCRL protein levels. This could help explain phenotypic differences seen in LS patients. For example, while every patient has the triad of congenital cataracts, IDD, and renal proximal tubular dysfunction, subgroups of patients have epilepsy, stereotypical behaviors, and glaucoma. In addition, this hypothesis could also help explain the more dramatic clinical differences seen in LS and patients with <italic>OCRL</italic>-associated DENT-2 disease, the latter of  which is characterized by renal disease, without eye and behavioral manifestations [<xref ref-type="bibr" rid="CR114">114</xref>–<xref ref-type="bibr" rid="CR117">117</xref>]. In addition, we previously found differences in the production of F-actin and WAVE-1 in LS NPCs compared with NPCs made from a null <italic>OCRL</italic> iPSC line that we generated using CRISPR-Cas9 gene editing [<xref ref-type="bibr" rid="CR27">27</xref>]. However, in that study, the LS500/LS600 pair showed the same abnormality as the other two patient/control sets. Thus, other factors need to be invoked to help explain the clinical and molecular heterogeneity seen in LS and DENT-2 disease, such as genetic background. Generating additional patient-specific lines, as well as creating null and patient-specific mutations using CRISPR-Cas9 gene editing in isogenic lines to control for genetic background, will be needed to sort through these intriguing possibilities.
<fig id="Fig5"><label>Fig. 5</label><caption><p>OCRL protein and RNA. OCRL RNA was analyzed by qPCR (top) as described in the Fig. <xref ref-type="fig" rid="Fig3">3</xref> legend. OCRL protein (bottom) was analyzed by Western blotting, as described in the methods section. The Western blot was done twice with two independent samples</p></caption><graphic id="MO5" xlink:href="11689_2020_9317_Fig5_HTML"></graphic></fig></p>
<p id="Par53">We presented our results by a combined analysis of the patient and control NPCs. We have also tried to identify DEGs between the LS samples and controls of each family. The sample size was small (<italic>n</italic> = 2), thus statistical power is weak, but a few thousand DEGs were detected at fold change &gt; 2 and adjusted <italic>p</italic> &lt; 0.05 between LS and their corresponding sibling NPC controls (data not shown). The overlap of the DEGs from the three families, however, was relatively small, indicating a high level of gene expression variation in these NPC samples. Additional LS/control sets, analysis of multiple clones from the same subjects, and analyzing isogenic control/CRISPR-edited lines will be needed to resolve this issue. We are currently generating such lines.</p>
<p id="Par54">As an alternative to DESeq2, we also applied the limma voom differentiation expression analysis [<xref ref-type="bibr" rid="CR118">118</xref>] to the jointed analysis of our samples, using its “duplicateCorrelation” function to account for two replicates per iPSC line. However, it did not yield DEGs by our statistical criteria of padj &lt; 0.05 (data not shown).</p>
<p id="Par55">Despite the lack of highly enriched pathways from our DEG analysis, a number of interesting candidate genes emerged that strongly suggest a role in the neurodevelopmental and eye problems associated with LS, and cellular phenotypes we previously identified in NPCs. As noted in the results section, four out of the top 16 DEGs genes are known SZ, ASD, IDD candidate genes (DPP10, GDA, PITX2, SPON1), and overall, there was a significant overlap between the 319 DEGs and ASD candidate genes (Fig. <xref ref-type="fig" rid="Fig2">2</xref>).</p>
<p id="Par56">Two other DEGs of note are <italic>TMEM132C</italic> and <italic>TMEM132D</italic>, which are feasible candidates for the F-actin/WAVE1 abnormalities we previously found in LS NPCs [<xref ref-type="bibr" rid="CR27">27</xref>]. These genes code for members of a family of transmembrane, cell-surface molecules expressed in the brain [<xref ref-type="bibr" rid="CR119">119</xref>]. TMEM132 proteins have an intracellular WAVE regulatory complex interacting receptor sequence cytoplasmic motif, which is a key regulator of actin polymerization by initiating F-actin nucleation through an interaction with the Arp2/3 complex [<xref ref-type="bibr" rid="CR120">120</xref>]. Whether TMEM132 proteins affect WAVE-1 expression in LS NPCs remains to be determined.</p>
<p id="Par57">One of the more interesting findings in the NPC transcriptome analysis are the DEGs implicated in eye pathology. This could represent differential expression in eye tissue that happen to be similarly affected in neural cells, or to common developmental pathways, although this remains to be determined. On the other hand, recent research suggests that some forms of glaucoma should be viewed as neurodegenerative disorders caused by retinal and optic nerve injury [<xref ref-type="bibr" rid="CR121">121</xref>, <xref ref-type="bibr" rid="CR122">122</xref>], so it is possible that the primary defect related to these DEGs is due to aberrant expression in neuronal cells.</p>
<p id="Par58">The most significant DEGs related to LS eye pathology are <italic>EFEMP1</italic>, <italic>MEIS2</italic>, and <italic>SPON1I</italic>, as noted above<italic>. EFEMP1</italic> is particularly interesting from a therapeutic perspective because it is connected to several potentially druggable pathways, including complement activation, the EGF receptor, and BMP7 and TGFβ2 signaling [<xref ref-type="bibr" rid="CR110">110</xref>, <xref ref-type="bibr" rid="CR123">123</xref>–<xref ref-type="bibr" rid="CR125">125</xref>]. In addition, EFEMP1, as a protein secreted into the extracellular matrix, could be a target for therapeutic intervention as well.</p>
<p id="Par59">With respect to <italic>EFEMP1</italic>, <italic>MEIS2</italic>, and <italic>SPON1</italic>, and glaucoma risk in LS, the fact that these genes have been implicated in glaucoma and other eye disorders suggests that understanding how they cause severe eye disease in LS could have much broader public health implications, considering the high prevalence of these conditions in the general population. Thus, the iPSC lines we have developed could be very useful for screening small molecule modulators of EFEMP1 and other eye-related DEGs for a wide range of eye disorders. Their role in eye pathology can now be analyzed in our iPSC model system since several protocols have been published for inducing differentiation into various types of eye tissues [<xref ref-type="bibr" rid="CR126">126</xref>, <xref ref-type="bibr" rid="CR127">127</xref>].</p>
</sec>
<sec id="Sec18">
<title>Limitations</title>
<p id="Par60">A limitation of the study is the sample size, which is a general limiting factor for most iPSC studies, considering the expense and time it takes to cultivate these lines. In addition, there is a dearth of protein and functional validation, which means that individual DEG findings may ultimately fail to be biologically relevant. Nevertheless, our findings are still of great interest because the differentially expressed genes are consistent with what is known about LS with respect to both neurodevelopmental and eye pathologies. We plan on increasing our sample size in the next year to improve the scientific rigor of future transcriptomic studies.</p>
</sec>
<sec id="Sec19">
<title>Conclusions</title>
<p id="Par61">RNA-seq analysis of iPSC-derived NPCs from patients with Lowe syndrome and their typically developing brothers identified 319 DEGs, which are enriched with genes that have been identified as ASD candidates. In addition, several DEGs code for genes that have been implicated in the development of cataracts, glaucoma, and retinal disease. Altered expression of these genes may play a role in the behavioral and ocular problems occurring in LS and connect this extremely rare condition at a pathophysiological level to a much wider population of disorders. The study also points to several feasible targets for therapeutic intervention.</p>
</sec>
<sec sec-type="supplementary-material">
<title>Supplementary information</title>
<sec id="Sec20">
<p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="11689_2020_9317_MOESM1_ESM.pdf_"><caption><p><bold>Additional file 1: Figure S1.</bold> Immunocytochemistry (ICC) of NPCs used in the RNA-seq study (one set) showing Vimentin and Sox2 staining (A and B, respectively) with a nuclear stain (DAPI).</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="11689_2020_9317_MOESM2_ESM.png"><caption><p><bold>Additional file 2: Figure S2.</bold> Pearson’s correlation coefficients of the gene expression between NPCs described in the current study and ~300 samples from the ENCODE project. Samples with coefficients &gt; 0.85 are shown and the highest correlations are NPCs from ENCODE (ENCFF663ARH), followed by a human neuroblastoma cell line, SK-N-DZ.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM3"><media xlink:href="11689_2020_9317_MOESM3_ESM.pdf"><caption><p><bold>Additional file 3: Table S1.</bold> Quality of RNA-seq Reads and Mapping. The number of reads, alignment rates, and reads across different gene regions are similar. The instrument ID, run number, lane number and flowcell ID were provided by the Novogene.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM4"><media xlink:href="11689_2020_9317_MOESM4_ESM.pdf"><caption><p><bold>Additional file 4: Figure S3.</bold> A and B. Sashimi plots of RNA-seq reads confirming cryptic splice in exon 24 in LS100, and loss of exon 23 in LS200, as described in Barnes et al. C. shows deletion of "C" in exon 20 in LS500.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM5"><media xlink:href="11689_2020_9317_MOESM5_ESM.xlsx"><caption><p><bold>Additional file 5:Table S2.</bold> Entire gene list arranged in descending order of significance level (pval), The top 16 genes with padj &lt; 0.1 are in bold type.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM6"><media xlink:href="11689_2020_9317_MOESM6_ESM.pdf"><caption><p><bold>Additional file 6: Figure S4.</bold> Gene Set Enrichment Analysis (GSEA) for genes that are up-regulated in controls (down-regulated in LS). GO terms were selected by nominal pval &lt; 0.01 because none passed FDR &lt; 25%.</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM7"><media xlink:href="11689_2020_9317_MOESM7_ESM.xlsx"><caption><p><bold>Additional file 7: Table S3.</bold> Overlap of nominal DEGs with ASD, ID, SZ and eye disease gene datasets. Citations are included in the table.</p></caption></media></supplementary-material>
</p>
</sec>
</sec>
</body>
<back>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item>
<term>DEG</term>
<def>
<p id="Par5">Differentially expressed gene</p>
</def>
</def-item>
<def-item>
<term>FPKM</term>
<def>
<p id="Par6">Fragments per kilobase of exon per million fragments mapped</p>
</def>
</def-item>
<def-item>
<term>FDR</term>
<def>
<p id="Par7">False discovery rate</p>
</def>
</def-item>
<def-item>
<term>GO</term>
<def>
<p id="Par8">Gene ontology</p>
</def>
</def-item>
<def-item>
<term>GWAS</term>
<def>
<p id="Par9">Genome-wide association study</p>
</def>
</def-item>
<def-item>
<term>iPSC</term>
<def>
<p id="Par10">Induced pluripotent stem cell</p>
</def>
</def-item>
<def-item>
<term>KO</term>
<def>
<p id="Par11">Knockout</p>
</def>
</def-item>
<def-item>
<term>NPC</term>
<def>
<p id="Par12">Neural progenitor cell</p>
</def>
</def-item>
<def-item>
<term>PCR</term>
<def>
<p id="Par13">Polymerase chain reaction</p>
</def>
</def-item>
<def-item>
<term>qPCR</term>
<def>
<p id="Par14">Quantitative real-time PCR</p>
</def>
</def-item>
<def-item>
<term>Pval</term>
<def>
<p id="Par15"><italic>P</italic> value</p>
</def>
</def-item>
<def-item>
<term>ASD</term>
<def>
<p id="Par16">Autism spectrum disorders</p>
</def>
</def-item>
<def-item>
<term>SZ</term>
<def>
<p id="Par17">Schizophrenia</p>
</def>
</def-item>
<def-item>
<term>BD</term>
<def>
<p id="Par18">Bipolar disorder</p>
</def>
</def-item>
<def-item>
<term>ICC</term>
<def>
<p id="Par19">Immunocytochemistry</p>
</def>
</def-item>
<def-item>
<term>PI(4,5)P2</term>
<def>
<p id="Par20">Phosphatidylinositol 4,5-bisphosphate</p>
</def>
</def-item>
<def-item>
<term>IRB</term>
<def>
<p id="Par21">Internal review board</p>
</def>
</def-item>
</def-list>
</glossary>
<fn-group>
<fn>
<p>
<bold>Publisher’s Note</bold>
</p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</fn>
<fn>
<p>Hequn Liu, Jesse Barnes, Deyou Zheng are shared equally..</p>
</fn>
</fn-group>
<sec>
<title>Supplementary information</title>
<p><bold>Supplementary information</bold> accompanies this paper at 10.1186/s11689-020-09317-2.</p>
</sec>
<ack>
<title>Acknowledgements</title>
<p>We are grateful to the New York State Department of Health (NYSTEM Program) for supporting the Einstein Comprehensive Human Pluripotent Stem Cell Center under the direction of Dr. Eric Bouhassira (NYSTEM C029154). The authors would also like to thank the participating families and Yang Sun, MD, PhD, for providing the RPE cell line.</p>
</ack>
<notes notes-type="author-contribution">
<title>Authors’ contributions</title>
<p>HL contributed in bioinformatics, data analysis, and manuscript preparation; JB conceived experiment, NPC cultures, protein isolation, and Western blotting; EP contributed in iPSC cultures and RNA isolation qPCR; NH contributed in qPCR; CB contributed in immunohistochemistry; FS contributed in literature search and preparation of tables; PW contributed in bioinformatics and data analysis; DZ contributed in bioinformatics, data analysis, and manuscript preparation; and HML conceived the experiment, manuscript preparation, and data analysis. All authors read and approved the final manuscript.</p>
</notes>
<notes notes-type="funding-information">
<title>Funding</title>
<p>This project was supported by pilot grants from the Lowe Syndrome Association and the Lowe Syndrome Foundation. HML is supported by a grant from NIMH National Institute of Mental Health (NIMH) (MH099427). This work was also supported in part by a grant to The Rose F. Kennedy Intellectual and Developmental Disabilities Research Center (RFK-IDDRC) from the Eunice Kennedy Shriver National Institute of Child Health &amp; Human Development (NICHD) at the NIH (1P30HD071593), and NICHD grant 6U54 HD 090260. JB is supported by The Einstein Training Program in Stem Cell Research of Albert Einstein College of Medicine, Inc. from the Empire State Stem Cell Fund through New York State Department of Health Contract C30292GG. Opinions expressed here are solely those of the author and do not necessarily reflect those of the Empire State Stem Cell Board, the New York State Department of Health, or the State of New York.</p>
</notes>
<notes notes-type="data-availability">
<title>Availability of data and materials</title>
<p>RNA-seq data can be accessed at the Gene Expression Omnibus (GEO), (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/">https://www.ncbi.nlm.nih.gov/geo/</ext-link>), accession number GSE129310, review token, yzuluyoyrtavdkr.</p>
</notes>
<notes id="FPar1">
<title>Ethics approval and consent to participate</title>
<p id="Par62">The study and consent forms were approved by the Albert Einstein College of Medicine Institutional Review Board (IRB). Consent was obtained by a skilled member of the research team who had received prior human subjects training.</p>
</notes>
<notes id="FPar2">
<title>Consent for publication</title>
<p id="Par63">Consent to publish findings and data was provided in the consent form, which was signed by all participants.</p>
</notes>
<notes id="FPar3" notes-type="COI-statement">
<title>Competing interests</title>
<p id="Par64">None.</p>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Silver</surname>
<given-names>DN</given-names>
</name>
<name>
<surname>Lewis</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Nussbaum</surname>
<given-names>RL</given-names>
</name>
</person-group>
<article-title>Mapping the Lowe oculocerebrorenal syndrome to Xq24-q26 by use of restriction fragment length polymorphisms</article-title>
<source/>J Clin Invest
          <year>1987</year>
<volume>79</volume>
<issue>1</issue>
<fpage>282</fpage>
<lpage>285</lpage>
<pub-id pub-id-type="doi">10.1172/JCI112795</pub-id>
<pub-id pub-id-type="pmid">2878939</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schurman</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Scheinman</surname>
<given-names>SJ</given-names>
</name>
</person-group>
<article-title>Inherited cerebrorenal syndromes</article-title>
<source/>Nat Rev Nephrol
          <year>2009</year>
<volume>5</volume>
<issue>9</issue>
<fpage>529</fpage>
<lpage>538</lpage>
<pub-id pub-id-type="doi">10.1038/nrneph.2009.124</pub-id>
<pub-id pub-id-type="pmid">19701229</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Waugh</surname>
<given-names>MG</given-names>
</name>
</person-group>
<article-title>PIPs in neurological diseases</article-title>
<source/>Biochim Biophys Acta
          <year>2015</year>
<volume>1851</volume>
<issue>8</issue>
<fpage>1066</fpage>
<lpage>1082</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbalip.2015.02.002</pub-id>
<pub-id pub-id-type="pmid">25680866</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Staiano</surname>
<given-names>L</given-names>
</name>
<name>
<surname>De Leo</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Persico</surname>
<given-names>M</given-names>
</name>
<name>
<surname>De Matteis</surname>
<given-names>MA</given-names>
</name>
</person-group>
<article-title>Mendelian disorders of PI metabolizing enzymes</article-title>
<source/>Biochim Biophys Acta
          <year>2015</year>
<volume>1851</volume>
<issue>6</issue>
<fpage>867</fpage>
<lpage>881</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbalip.2014.12.001</pub-id>
<pub-id pub-id-type="pmid">25510381</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<mixed-citation publication-type="other">Lewis RA, Nussbaum RL, Brewer ED. Lowe syndrome. In GeneReviews(R). Edited by Adam MP, Ardinger HH, Pagon RA, et al. Seattle (WA): University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved; 1993.</mixed-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Matteis</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Staiano</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Emma</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Devuyst</surname>
<given-names>O</given-names>
</name>
</person-group>
<article-title>The 5-phosphatase OCRL in Lowe syndrome and Dent disease 2</article-title>
<source/>Nat Rev Nephrol
          <year>2017</year>
<volume>13</volume>
<issue>8</issue>
<fpage>455</fpage>
<lpage>470</lpage>
<pub-id pub-id-type="doi">10.1038/nrneph.2017.83</pub-id>
<pub-id pub-id-type="pmid">28669993</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prosseda</surname>
<given-names>PP</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Alvarado</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Loss of OCRL increases ciliary PI(4,5)P2 in Lowe oculocerebrorenal syndrome</article-title>
<source/>J Cell Sci
          <year>2017</year>
<volume>130</volume>
<issue>20</issue>
<fpage>3447</fpage>
<lpage>3454</lpage>
<pub-id pub-id-type="doi">10.1242/jcs.200857</pub-id>
<pub-id pub-id-type="pmid">28871046</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luo</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Conwell</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Kettenhofen</surname>
<given-names>CI</given-names>
</name>
<name>
<surname>Westlake</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Cantor</surname>
<given-names>LB</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Primary cilia signaling mediates intraocular pressure sensation</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2014</year>
<volume>111</volume>
<issue>35</issue>
<fpage>12871</fpage>
<lpage>12876</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1323292111</pub-id>
<pub-id pub-id-type="pmid">25143588</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Inoue</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Balkin</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Nandez</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>X</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Kidney tubular ablation of Ocrl/Inpp5b Phenocopies Lowe syndrome Tubulopathy</article-title>
<source/>J Am Soc Nephrol
          <year>2017</year>
<volume>28</volume>
<issue>5</issue>
<fpage>1399</fpage>
<lpage>1407</lpage>
<pub-id pub-id-type="doi">10.1681/ASN.2016080913</pub-id>
<pub-id pub-id-type="pmid">27895154</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nakatsu</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Messa</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nandez</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Czapla</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Zou</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Strittmatter</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>De Camilli</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Sac2/INPP5F is an inositol 4-phosphatase that functions in the endocytic pathway</article-title>
<source/>J Cell Biol
          <year>2015</year>
<volume>209</volume>
<issue>1</issue>
<fpage>85</fpage>
<lpage>95</lpage>
<pub-id pub-id-type="doi">10.1083/jcb.201409064</pub-id>
<pub-id pub-id-type="pmid">25869668</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vicinanza</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Di Campli</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Polishchuk</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Santoro</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Di Tullio</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Godi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Levtchenko</surname>
<given-names>E</given-names>
</name>
<name>
<surname>De Leo</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Polishchuk</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Sandoval</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Marzolo</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>De Matteis</surname>
<given-names>MA</given-names>
</name>
</person-group>
<article-title>OCRL controls trafficking through early endosomes via PtdIns4,5P(2)-dependent regulation of endosomal actin</article-title>
<source/>EMBO J
          <year>2011</year>
<volume>30</volume>
<issue>24</issue>
<fpage>4970</fpage>
<lpage>4985</lpage>
<pub-id pub-id-type="doi">10.1038/emboj.2011.354</pub-id>
<pub-id pub-id-type="pmid">21971085</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McCrea</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Paradise</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tomasini</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Addis</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Melis</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>De Matteis</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>De Camilli</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>All known patient mutations in the ASH-RhoGAP domains of OCRL affect targeting and APPL1 binding</article-title>
<source/>Biochem Biophys Res Commun
          <year>2008</year>
<volume>369</volume>
<issue>2</issue>
<fpage>493</fpage>
<lpage>499</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbrc.2008.02.067</pub-id>
<pub-id pub-id-type="pmid">18307981</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nandez</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Balkin</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Messa</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Paradise</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Czapla</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Hein</surname>
<given-names>MY</given-names>
</name>
<name>
<surname>Duncan</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Mann</surname>
<given-names>M</given-names>
</name>
<name>
<surname>De Camilli</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>A role of OCRL in clathrin-coated pit dynamics and uncoating revealed by studies of Lowe syndrome cells</article-title>
<source/>Elife
          <year>2014</year>
<volume>3</volume>
<fpage>e02975</fpage>
<pub-id pub-id-type="doi">10.7554/eLife.02975</pub-id>
<pub-id pub-id-type="pmid">25107275</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pirruccello</surname>
<given-names>M</given-names>
</name>
<name>
<surname>De Camilli</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Inositol 5-phosphatases: insights from the Lowe syndrome protein OCRL</article-title>
<source/>Trends Biochem Sci
          <year>2012</year>
<volume>37</volume>
<issue>4</issue>
<fpage>134</fpage>
<lpage>143</lpage>
<pub-id pub-id-type="doi">10.1016/j.tibs.2012.01.002</pub-id>
<pub-id pub-id-type="pmid">22381590</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Jefferson</surname>
<given-names>AB</given-names>
</name>
<name>
<surname>Auethavekiat</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Majerus</surname>
<given-names>PW</given-names>
</name>
</person-group>
<article-title>The protein deficient in Lowe syndrome is a phosphatidylinositol-4,5-bisphosphate 5-phosphatase</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>1995</year>
<volume>92</volume>
<issue>11</issue>
<fpage>4853</fpage>
<lpage>4856</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.92.11.4853</pub-id>
<pub-id pub-id-type="pmid">7761412</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Hartz</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Philip</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Racusen</surname>
<given-names>LC</given-names>
</name>
<name>
<surname>Majerus</surname>
<given-names>PW</given-names>
</name>
</person-group>
<article-title>Cell lines from kidney proximal tubules of a patient with Lowe syndrome lack OCRL inositol polyphosphate 5-phosphatase and accumulate phosphatidylinositol 4,5-bisphosphate</article-title>
<source/>J Biol Chem
          <year>1998</year>
<volume>273</volume>
<issue>3</issue>
<fpage>1574</fpage>
<lpage>1582</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.273.3.1574</pub-id>
<pub-id pub-id-type="pmid">9430698</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Madhivanan</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ramadesikan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Aguilar</surname>
<given-names>RC</given-names>
</name>
</person-group>
<article-title>Role of Ocrl1 in primary cilia assembly</article-title>
<source/>Int Rev Cell Mol Biol
          <year>2015</year>
<volume>317</volume>
<fpage>331</fpage>
<lpage>347</lpage>
<pub-id pub-id-type="doi">10.1016/bs.ircmb.2015.02.003</pub-id>
<pub-id pub-id-type="pmid">26008789</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rbaibi</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Mo</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Carattino</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rohatgi</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Satlin</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Szalinski</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Swanhart</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Folsch</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Hukriede</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Weisz</surname>
<given-names>OA</given-names>
</name>
</person-group>
<article-title>OCRL1 modulates cilia length in renal epithelial cells</article-title>
<source/>Traffic
          <year>2012</year>
<volume>13</volume>
<issue>9</issue>
<fpage>1295</fpage>
<lpage>1305</lpage>
<pub-id pub-id-type="doi">10.1111/j.1600-0854.2012.01387.x</pub-id>
<pub-id pub-id-type="pmid">22680056</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luo</surname>
<given-names>N</given-names>
</name>
<name>
<surname>West</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Murga-Zamalloa</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Wells</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Weinreb</surname>
<given-names>RN</given-names>
</name>
<name>
<surname>Travers</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Khanna</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>OCRL localizes to the primary cilium: a new role for cilia in Lowe syndrome</article-title>
<source/>Hum Mol Genet
          <year>2012</year>
<volume>21</volume>
<issue>15</issue>
<fpage>3333</fpage>
<lpage>3344</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/dds163</pub-id>
<pub-id pub-id-type="pmid">22543976</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sharma</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Skowronek</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Erdmann</surname>
<given-names>KS</given-names>
</name>
</person-group>
<article-title>The role of the Lowe syndrome protein OCRL in the endocytic pathway</article-title>
<source/>Biol Chem
          <year>2015</year>
<volume>396</volume>
<issue>12</issue>
<fpage>1293</fpage>
<lpage>1300</lpage>
<pub-id pub-id-type="doi">10.1515/hsz-2015-0180</pub-id>
<pub-id pub-id-type="pmid">26351914</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ungewickell</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ward</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Ungewickell</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Majerus</surname>
<given-names>PW</given-names>
</name>
</person-group>
<article-title>The inositol polyphosphate 5-phosphatase Ocrl associates with endosomes that are partially coated with clathrin</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2004</year>
<volume>101</volume>
<issue>37</issue>
<fpage>13501</fpage>
<lpage>13506</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0405664101</pub-id>
<pub-id pub-id-type="pmid">15353600</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramirez</surname>
<given-names>IB</given-names>
</name>
<name>
<surname>Pietka</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Divecha</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Alia</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Baraban</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Hurlstone</surname>
<given-names>AF</given-names>
</name>
<name>
<surname>Lowe</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Impaired neural development in a zebrafish model for Lowe syndrome</article-title>
<source/>Hum Mol Genet
          <year>2012</year>
<volume>21</volume>
<issue>8</issue>
<fpage>1744</fpage>
<lpage>1759</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddr608</pub-id>
<pub-id pub-id-type="pmid">22210625</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suchy</surname>
<given-names>SF</given-names>
</name>
<name>
<surname>Nussbaum</surname>
<given-names>RL</given-names>
</name>
</person-group>
<article-title>The deficiency of PIP2 5-phosphatase in Lowe syndrome affects actin polymerization</article-title>
<source/>Am J Hum Genet
          <year>2002</year>
<volume>71</volume>
<issue>6</issue>
<fpage>1420</fpage>
<lpage>1427</lpage>
<pub-id pub-id-type="doi">10.1086/344517</pub-id>
<pub-id pub-id-type="pmid">12428211</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bothwell</surname>
<given-names>SP</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Bernardini</surname>
<given-names>IM</given-names>
</name>
<name>
<surname>Kuo</surname>
<given-names>YM</given-names>
</name>
<name>
<surname>Gahl</surname>
<given-names>WA</given-names>
</name>
<name>
<surname>Nussbaum</surname>
<given-names>RL</given-names>
</name>
</person-group>
<article-title>Mouse model for Lowe syndrome/Dent disease 2 renal tubulopathy</article-title>
<source/>J Am Soc Nephrol
          <year>2011</year>
<volume>22</volume>
<issue>3</issue>
<fpage>443</fpage>
<lpage>448</lpage>
<pub-id pub-id-type="doi">10.1681/ASN.2010050565</pub-id>
<pub-id pub-id-type="pmid">21183592</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Janne</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Suchy</surname>
<given-names>SF</given-names>
</name>
<name>
<surname>Bernard</surname>
<given-names>D</given-names>
</name>
<name>
<surname>MacDonald</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Crawley</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Grinberg</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wynshaw-Boris</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Westphal</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Nussbaum</surname>
<given-names>RL</given-names>
</name>
</person-group>
<article-title>Functional overlap between murine Inpp5b and Ocrl1 may explain why deficiency of the murine ortholog for OCRL1 does not cause Lowe syndrome in mice</article-title>
<source/>J Clin Invest
          <year>1998</year>
<volume>101</volume>
<issue>10</issue>
<fpage>2042</fpage>
<lpage>2053</lpage>
<pub-id pub-id-type="doi">10.1172/JCI2414</pub-id>
<pub-id pub-id-type="pmid">9593760</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<mixed-citation publication-type="other">Festa BP, Berquez M, Gassama A, Amrein I, Ismail HM, Samardzija M, Staiano L, Luciani A, Grimm C, Nussbaum RL, De Matteis MA, Dorchies OM, Scapozza L, Wolfer DP, Devuyst O: OCRL Deficiency impairs endolysosomal function in a humanized mouse model for Lowe syndrome and Dent disease. Hum Mol Genet 2018.</mixed-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<mixed-citation publication-type="other">Barnes J, Salas F, Mokhtari R, Dolstra H, Pedrosa E, Lachman HM: Modeling the neuropsychiatric manifestations of Lowe syndrome using induced pluripotent stem cells: defective F-actin polymerization and WAVE-1 expression in neuronal cells. Mol Autism 2018, 9;44 doi: 10.1186/s13229-018-0227-3. eCollection 2018.</mixed-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<mixed-citation publication-type="other">Wang P, Mokhtari R, Pedrosa E, Kirschenbaum M, Bayrak C, Zheng D, Lachman HM: CRISPR/Cas9-mediated heterozygous knockout of the autism gene CHD8 and characterization of its transcriptional networks in cerebral organoids derived from iPS cells. Mol Autism 2017, 8;11 doi: 10.1186/s13229-017-0124-1. eCollection 2017.</mixed-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<mixed-citation publication-type="other">Zhao D, Mokhtari R, Pedrosa E, Birnbaum R, Zheng D, Lachman HM: Transcriptome analysis of microglia in a mouse model of Rett syndrome: differential expression of genes associated with microglia/macrophage activation and cellular stress. Mol Autism 2017, 8;17 doi: 10.1186/s13229-017-0134-z. eCollection 2017.</mixed-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<mixed-citation publication-type="other">Wang P, Lin M, Pedrosa E, Hrabovsky A, Zhang Z, Guo W, Lachman HM, Zheng D: CRISPR/Cas9-mediated heterozygous knockout of the autism gene CHD8 and characterization of its transcriptional networks in neurodevelopment. Mol Autism 2015, 6;55 doi: 10.1186/s13229-015-0048-6. eCollection 2015.</mixed-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Camp</surname>
<given-names>JG</given-names>
</name>
<name>
<surname>Badsha</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Florio</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kanton</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gerber</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Wilsch-Brauninger</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lewitus</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Sykes</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hevers</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Lancaster</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Knoblich</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Lachmann</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Paabo</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Huttner</surname>
<given-names>WB</given-names>
</name>
<name>
<surname>Treutlein</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Human cerebral organoids recapitulate gene expression programs of fetal neocortex development</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2015</year>
<volume>112</volume>
<issue>51</issue>
<fpage>15672</fpage>
<lpage>15677</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1520760112</pub-id>
<pub-id pub-id-type="pmid">26644564</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mariani</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Coppola</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Abyzov</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Provini</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Tomasini</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Amenduni</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Szekely</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Palejev</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gerstein</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Grigorenko</surname>
<given-names>EL</given-names>
</name>
<name>
<surname>Chawarska</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Pelphrey</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Howe</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Vaccarino</surname>
<given-names>FM</given-names>
</name>
</person-group>
<article-title>FOXG1-dependent dysregulation of GABA/glutamate neuron differentiation in autism spectrum disorders</article-title>
<source/>Cell
          <year>2015</year>
<volume>162</volume>
<issue>2</issue>
<fpage>375</fpage>
<lpage>390</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2015.06.034</pub-id>
<pub-id pub-id-type="pmid">26186191</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lachman</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Transcriptomics analysis of iPSC-derived neurons and modeling of neuropsychiatric disorders</article-title>
<source/>Mol Cell Neurosci
          <year>2016</year>
<volume>73</volume>
<fpage>32</fpage>
<lpage>42</lpage>
<pub-id pub-id-type="doi">10.1016/j.mcn.2015.11.009</pub-id>
<pub-id pub-id-type="pmid">26631648</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>O'Shea</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>McInnis</surname>
<given-names>MG</given-names>
</name>
</person-group>
<article-title>Neurodevelopmental origins of bipolar disorder: iPSC models</article-title>
<source/>Mol Cell Neurosci
          <year>2016</year>
<volume>73</volume>
<fpage>63</fpage>
<lpage>83</lpage>
<pub-id pub-id-type="doi">10.1016/j.mcn.2015.11.006</pub-id>
<pub-id pub-id-type="pmid">26608002</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>ZN</given-names>
</name>
<name>
<surname>Freitas</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Qian</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Lux</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Acab</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Trujillo</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Herai</surname>
<given-names>RH</given-names>
</name>
<name>
<surname>Nguyen Huu</surname>
<given-names>VA</given-names>
</name>
<name>
<surname>Wen</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Joshi-Barr</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Karpiak</surname>
<given-names>JV</given-names>
</name>
<name>
<surname>Engler</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>XD</given-names>
</name>
<name>
<surname>Muotri</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Almutairi</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Layered hydrogels accelerate iPSC-derived neuronal maturation and reveal migration defects caused by MeCP2 dysfunction</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2016</year>
<volume>113</volume>
<issue>12</issue>
<fpage>3185</fpage>
<lpage>3190</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1521255113</pub-id>
<pub-id pub-id-type="pmid">26944080</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Olivier</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bouhassira</surname>
<given-names>EE</given-names>
</name>
</person-group>
<article-title>Novel, high-yield red blood cell production methods from CD34-positive cells derived from human embryonic stem, yolk sac, fetal liver, cord blood, and peripheral blood</article-title>
<source/>Stem Cells Transl Med
          <year>2012</year>
<volume>1</volume>
<issue>8</issue>
<fpage>604</fpage>
<lpage>614</lpage>
<pub-id pub-id-type="doi">10.5966/sctm.2012-0059</pub-id>
<pub-id pub-id-type="pmid">23197866</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Davis</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Hitz</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Sloan</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>ET</given-names>
</name>
<name>
<surname>Davidson</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Gabdank</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Hilton</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Jain</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Baymuradov</surname>
<given-names>UK</given-names>
</name>
<name>
<surname>Narayanan</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Onate</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>Graham</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Miyasato</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Dreszer</surname>
<given-names>TR</given-names>
</name>
<name>
<surname>Strattan</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Jolanki</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>FY</given-names>
</name>
<name>
<surname>Cherry</surname>
<given-names>JM</given-names>
</name>
</person-group>
<article-title>The encyclopedia of DNA elements (ENCODE): data portal update</article-title>
<source/>Nucleic Acids Res
          <year>2018</year>
<volume>46</volume>
<issue>D1</issue>
<fpage>D794</fpage>
<lpage>D801</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkx1081</pub-id>
<pub-id pub-id-type="pmid">29126249</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Langmead</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Salzberg</surname>
<given-names>SL</given-names>
</name>
</person-group>
<article-title>HISAT: a fast spliced aligner with low memory requirements</article-title>
<source/>Nat Methods
          <year>2015</year>
<volume>12</volume>
<issue>4</issue>
<fpage>357</fpage>
<lpage>360</lpage>
<pub-id pub-id-type="doi">10.1038/nmeth.3317</pub-id>
<pub-id pub-id-type="pmid">25751142</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anders</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Pyl</surname>
<given-names>PT</given-names>
</name>
<name>
<surname>Huber</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>HTSeq--a python framework to work with high-throughput sequencing data</article-title>
<source/>Bioinformatics
          <year>2015</year>
<volume>31</volume>
<issue>2</issue>
<fpage>166</fpage>
<lpage>169</lpage>
<pub-id pub-id-type="doi">10.1093/bioinformatics/btu638</pub-id>
<pub-id pub-id-type="pmid">25260700</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pertea</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pertea</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Antonescu</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>TC</given-names>
</name>
<name>
<surname>Mendell</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Salzberg</surname>
<given-names>SL</given-names>
</name>
</person-group>
<article-title>StringTie enables improved reconstruction of a transcriptome from RNA-seq reads</article-title>
<source/>Nat Biotechnol
          <year>2015</year>
<volume>33</volume>
<issue>3</issue>
<fpage>290</fpage>
<lpage>295</lpage>
<pub-id pub-id-type="doi">10.1038/nbt.3122</pub-id>
<pub-id pub-id-type="pmid">25690850</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harrow</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Frankish</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gonzalez</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Tapanari</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Diekhans</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kokocinski</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Aken</surname>
<given-names>BL</given-names>
</name>
<name>
<surname>Barrell</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Zadissa</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Searle</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Barnes</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Bignell</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Boychenko</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Hunt</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kay</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mukherjee</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Rajan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Despacio-Reyes</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Saunders</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Steward</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Harte</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Howald</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Tanzer</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Derrien</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Chrast</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Walters</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Balasubramanian</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Pei</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Tress</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rodriguez</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Ezkurdia</surname>
<given-names>I</given-names>
</name>
<name>
<surname>van Baren</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Brent</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Haussler</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Kellis</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Valencia</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Reymond</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gerstein</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Guigo</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Hubbard</surname>
<given-names>TJ</given-names>
</name>
</person-group>
<article-title>GENCODE: the reference human genome annotation for The ENCODE Project</article-title>
<source/>Genome Res
          <year>2012</year>
<volume>22</volume>
<issue>9</issue>
<fpage>1760</fpage>
<lpage>1774</lpage>
<pub-id pub-id-type="doi">10.1101/gr.135350.111</pub-id>
<pub-id pub-id-type="pmid">22955987</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Love</surname>
<given-names>MI</given-names>
</name>
<name>
<surname>Huber</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Anders</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title>
<source/>Genome Biol
          <year>2014</year>
<volume>15</volume>
<issue>12</issue>
<fpage>550</fpage>
<pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id>
<pub-id pub-id-type="pmid">25516281</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hrabovsky</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Pedrosa</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Dean</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Jain</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Lachman</surname>
<given-names>HM</given-names>
</name>
</person-group>
<article-title>ZNF804A transcriptional networks in differentiating neurons derived from induced pluripotent stem cells of human origin</article-title>
<source/>PLoS One
          <year>2015</year>
<volume>10</volume>
<issue>4</issue>
<fpage>e0124597</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0124597</pub-id>
<pub-id pub-id-type="pmid">25905630</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Subramanian</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Tamayo</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Mootha</surname>
<given-names>VK</given-names>
</name>
<name>
<surname>Mukherjee</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ebert</surname>
<given-names>BL</given-names>
</name>
<name>
<surname>Gillette</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Paulovich</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Pomeroy</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Golub</surname>
<given-names>TR</given-names>
</name>
<name>
<surname>Lander</surname>
<given-names>ES</given-names>
</name>
<name>
<surname>Mesirov</surname>
<given-names>JP</given-names>
</name>
</person-group>
<article-title>Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2005</year>
<volume>102</volume>
<issue>43</issue>
<fpage>15545</fpage>
<lpage>15550</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0506580102</pub-id>
<pub-id pub-id-type="pmid">16199517</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mootha</surname>
<given-names>VK</given-names>
</name>
<name>
<surname>Lindgren</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Eriksson</surname>
<given-names>KF</given-names>
</name>
<name>
<surname>Subramanian</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sihag</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lehar</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Puigserver</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Carlsson</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Ridderstrale</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Laurila</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Houstis</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Daly</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Patterson</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Mesirov</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Golub</surname>
<given-names>TR</given-names>
</name>
<name>
<surname>Tamayo</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Spiegelman</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Lander</surname>
<given-names>ES</given-names>
</name>
<name>
<surname>Hirschhorn</surname>
<given-names>JN</given-names>
</name>
<name>
<surname>Altshuler</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Groop</surname>
<given-names>LC</given-names>
</name>
</person-group>
<article-title>PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes</article-title>
<source/>Nat Genet
          <year>2003</year>
<volume>34</volume>
<issue>3</issue>
<fpage>267</fpage>
<lpage>273</lpage>
<pub-id pub-id-type="doi">10.1038/ng1180</pub-id>
<pub-id pub-id-type="pmid">12808457</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abrahams</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Arking</surname>
<given-names>DE</given-names>
</name>
<name>
<surname>Campbell</surname>
<given-names>DB</given-names>
</name>
<name>
<surname>Mefford</surname>
<given-names>HC</given-names>
</name>
<name>
<surname>Morrow</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Weiss</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Menashe</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Wadkins</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Banerjee-Basu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Packer</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>SFARI Gene 2.0: a community-driven knowledgebase for the autism spectrum disorders (ASDs)</article-title>
<source/>Mol Autism
          <year>2013</year>
<volume>4</volume>
<issue>1</issue>
<fpage>36</fpage>
<pub-id pub-id-type="doi">10.1186/2040-2392-4-36</pub-id>
<pub-id pub-id-type="pmid">24090431</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iossifov</surname>
<given-names>I</given-names>
</name>
<name>
<surname>O'Roak</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Sanders</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Ronemus</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Krumm</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Levy</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Stessman</surname>
<given-names>HA</given-names>
</name>
<name>
<surname>Witherspoon</surname>
<given-names>KT</given-names>
</name>
<name>
<surname>Vives</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Patterson</surname>
<given-names>KE</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Paeper</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Nickerson</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Dea</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gonzalez</surname>
<given-names>LE</given-names>
</name>
<name>
<surname>Mandell</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Mane</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Murtha</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Sullivan</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Waqar</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Willsey</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Yamrom</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>YH</given-names>
</name>
<name>
<surname>Grabowska</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Dalkic</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Marks</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Andrews</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Leotta</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kendall</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hakker</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Rosenbaum</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Rodgers</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Troge</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Narzisi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Yoon</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Schatz</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>K</given-names>
</name>
<name>
<surname>WR</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Shendure</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Eichler</surname>
<given-names>EE</given-names>
</name>
<name>
<surname>State</surname>
<given-names>MW</given-names>
</name>
<name>
<surname>Wigler</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>The contribution of de novo coding mutations to autism spectrum disorder</article-title>
<source/>Nature
          <year>2014</year>
<volume>515</volume>
<issue>7526</issue>
<fpage>216</fpage>
<lpage>221</lpage>
<pub-id pub-id-type="doi">10.1038/nature13908</pub-id>
<pub-id pub-id-type="pmid">25363768</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>AutismKB: an evidence-based knowledgebase of autism genetics</article-title>
<source/>Nucleic Acids Res
          <year>2012</year>
<volume>40</volume>
<issue>Database issue</issue>
<fpage>D1016</fpage>
<lpage>D1022</lpage>
<pub-id pub-id-type="doi">10.1093/nar/gkr1145</pub-id>
<pub-id pub-id-type="pmid">22139918</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Willsey</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Sanders</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tebbenkamp</surname>
<given-names>AT</given-names>
</name>
<name>
<surname>Muhle</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Reilly</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Fertuzinhos</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Murtha</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Bichsel</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Niu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Cotney</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ercan-Sencicek</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Gockley</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>W</given-names>
</name>
<name>
<surname>He</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Hoffman</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Klei</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Lei</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Mane</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Lein</surname>
<given-names>ES</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Noonan</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Roeder</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Devlin</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Sestan</surname>
<given-names>N</given-names>
</name>
<name>
<surname>State</surname>
<given-names>MW</given-names>
</name>
</person-group>
<article-title>Coexpression networks implicate human midfetal deep cortical projection neurons in the pathogenesis of autism</article-title>
<source/>Cell
          <year>2013</year>
<volume>155</volume>
<issue>5</issue>
<fpage>997</fpage>
<lpage>1007</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2013.10.020</pub-id>
<pub-id pub-id-type="pmid">24267886</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Lei</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Sanders</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Willsey</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Kou</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Cicek</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Klei</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>He</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Muhle</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Ma'ayan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Noonan</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Sestan</surname>
<given-names>N</given-names>
</name>
<name>
<surname>McFadden</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>State</surname>
<given-names>MW</given-names>
</name>
<name>
<surname>Buxbaum</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Devlin</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Roeder</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>DAWN: a framework to identify autism genes and subnetworks using gene expression and genetics</article-title>
<source/>Mol Autism
          <year>2014</year>
<volume>5</volume>
<issue>1</issue>
<fpage>22</fpage>
<pub-id pub-id-type="doi">10.1186/2040-2392-5-22</pub-id>
<pub-id pub-id-type="pmid">24602502</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Rubeis</surname>
<given-names>S</given-names>
</name>
<name>
<surname>He</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Goldberg</surname>
<given-names>AP</given-names>
</name>
<name>
<surname>Poultney</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Samocha</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Cicek</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Kou</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Fromer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Klei</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Kosmicki</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Shih-Chen</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Aleksic</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Biscaldi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bolton</surname>
<given-names>PF</given-names>
</name>
<name>
<surname>Brownfeld</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Campbell</surname>
<given-names>NG</given-names>
</name>
<name>
<surname>Carracedo</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Chahrour</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Chiocchetti</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Coon</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Crawford</surname>
<given-names>EL</given-names>
</name>
<name>
<surname>Curran</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Dawson</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Duketis</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Fernandez</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Gallagher</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Geller</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Guter</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Hill</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Ionita-Laza</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Jimenz Gonzalez</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Kilpinen</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Klauck</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Kolevzon</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Lei</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Lei</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lehtimaki</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>CF</given-names>
</name>
<name>
<surname>Ma'ayan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Marshall</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>AL</surname>
<given-names>MI</given-names>
</name>
<name>
<surname>Neale</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Owen</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Ozaki</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Parellada</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Parr</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Purcell</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Puura</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Rajagopalan</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Rehnstrom</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Reichenberg</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sabo</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sachse</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sanders</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Schafer</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Schulte-Ruther</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Skuse</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Stevens</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Szatmari</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Tammimies</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Valladares</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Voran</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Li-San</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Weiss</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Willsey</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>TW</given-names>
</name>
<name>
<surname>Yuen</surname>
<given-names>RK</given-names>
</name>
<collab>DDD Study, Homozygosity Mapping Collaborative for Autism, UK10K Consortium</collab>
<name>
<surname>Cook</surname>
<given-names>EH</given-names>
</name>
<name>
<surname>Freitag</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Gill</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hultman</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Lehner</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Palotie</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Schellenberg</surname>
<given-names>GD</given-names>
</name>
<name>
<surname>Sklar</surname>
<given-names>P</given-names>
</name>
<name>
<surname>State</surname>
<given-names>MW</given-names>
</name>
<name>
<surname>Sutcliffe</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Walsh</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Scherer</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Zwick</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Barett</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Cutler</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Roeder</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Devlin</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Daly</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Buxbaum</surname>
<given-names>JD</given-names>
</name>
</person-group>
<article-title>Synaptic, transcriptional and chromatin genes disrupted in autism</article-title>
<source/>Nature
          <year>2014</year>
<volume>515</volume>
<issue>7526</issue>
<fpage>209</fpage>
<lpage>215</lpage>
<pub-id pub-id-type="doi">10.1038/nature13772</pub-id>
<pub-id pub-id-type="pmid">25363760</pub-id>
</element-citation>
</ref>
<ref id="CR52">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Allen</surname>
<given-names>NC</given-names>
</name>
<name>
<surname>Bagade</surname>
<given-names>S</given-names>
</name>
<name>
<surname>McQueen</surname>
<given-names>MB</given-names>
</name>
<name>
<surname>Ioannidis</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Kavvoura</surname>
<given-names>FK</given-names>
</name>
<name>
<surname>Khoury</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Tanzi</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Bertram</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database</article-title>
<source/>Nat Genet
          <year>2008</year>
<volume>40</volume>
<issue>7</issue>
<fpage>827</fpage>
<lpage>834</lpage>
<pub-id pub-id-type="doi">10.1038/ng.171</pub-id>
<pub-id pub-id-type="pmid">18583979</pub-id>
</element-citation>
</ref>
<ref id="CR53">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<collab>Schizophrenia Working Group of the Psychiatric Genomics Consortium</collab>
</person-group>
<article-title>Biological insights from 108 schizophrenia-associated genetic loci</article-title>
<source/>Nature
          <year>2014</year>
<volume>511</volume>
<issue>7510</issue>
<fpage>421</fpage>
<lpage>427</lpage>
<pub-id pub-id-type="doi">10.1038/nature13595</pub-id>
<pub-id pub-id-type="pmid">25056061</pub-id>
</element-citation>
</ref>
<ref id="CR54">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fatima</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Farooq</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Abdullah</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Tariq</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mustafa</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Iqbal</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tommerup</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Mahmood Baig</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Genome-wide supported risk variants in MIR137, CACNA1C, CSMD1, DRD2, and GRM3 contribute to schizophrenia susceptibility in Pakistani population</article-title>
<source/>Psychiatry Investig
          <year>2017</year>
<volume>14</volume>
<issue>5</issue>
<fpage>687</fpage>
<lpage>692</lpage>
<pub-id pub-id-type="doi">10.4306/pi.2017.14.5.687</pub-id>
<pub-id pub-id-type="pmid">29042896</pub-id>
</element-citation>
</ref>
<ref id="CR55">
<label>55.</label>
<mixed-citation publication-type="other">Ortega-Alonso A, Ekelund J, Sarin AP, Miettunen J, Veijola J, Jarvelin MR, Hennah W: Genome-wide association study of psychosis proneness in the Finnish population. Schizophr Bull 2017.</mixed-citation>
</ref>
<ref id="CR56">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hamshere</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Walters</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Richards</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Grozeva</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Forty</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Gordon-Smith</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Riley</surname>
<given-names>B</given-names>
</name>
<name>
<surname>O'Neill</surname>
<given-names>FA</given-names>
</name>
<name>
<surname>Kendler</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>Sklar</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Purcell</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kranz</surname>
<given-names>J</given-names>
</name>
<collab>Schizophrenia psychiatric genome-wide association study consortium</collab>
<collab>Wellcome Trust Case Control Consortium+</collab>
<collab>Wellcome Trust Case Control Consortium 2</collab>
<name>
<surname>Morris</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Gill</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Holmans</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Craddock</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Corvin</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Owen</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>O'Donovan</surname>
<given-names>MC</given-names>
</name>
</person-group>
<article-title>Genome-wide significant associations in schizophrenia to ITIH3/4, CACNA1C and SDCCAG8, and extensive replication of associations reported by the Schizophrenia PGC</article-title>
<source/>Mol Psychiatry
          <year>2013</year>
<volume>18</volume>
<issue>6</issue>
<fpage>708</fpage>
<lpage>712</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2012.67</pub-id>
<pub-id pub-id-type="pmid">22614287</pub-id>
</element-citation>
</ref>
<ref id="CR57">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lett</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Zai</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Tiwari</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Shaikh</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Likhodi</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Kennedy</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Muller</surname>
<given-names>DJ</given-names>
</name>
</person-group>
<article-title>ANK3, CACNA1C and ZNF804A gene variants in bipolar disorders and psychosis subphenotype</article-title>
<source/>World J Biol Psychiatry
          <year>2011</year>
<volume>12</volume>
<issue>5</issue>
<fpage>392</fpage>
<lpage>397</lpage>
<pub-id pub-id-type="doi">10.3109/15622975.2011.564655</pub-id>
<pub-id pub-id-type="pmid">21767209</pub-id>
</element-citation>
</ref>
<ref id="CR58">
<label>58.</label>
<mixed-citation publication-type="other">Sklar P, Smoller JW, Fan J, Ferreira MA, Perlis RH, Chambert K, Nimgaonkar VL, McQueen MB, Faraone SV, Kirby A, de Bakker PI, Ogdie MN, Thase ME, Sachs GS, Todd-Brown K, Gabriel SB, Sougnez C, Gates C, Blumenstiel B, Defelice M, Ardlie KG, Franklin J, Muir WJ, McGhee KA, Macintyre DJ, McLean A, Vanbeck M, McQuillin A, Bass NJ, Robinson M, Lawrence J, Anjorin A, Curtis D, Scolnick EM, Daly MJ, Blackwood DH, Gurling HM, Purcell SM: Whole-genome association study of bipolar disorder. Mol Psychiatry 2008.</mixed-citation>
</ref>
<ref id="CR59">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Lv</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>CACNA1C (rs1006737) may be a susceptibility gene for schizophrenia: an updated meta-analysis</article-title>
<source/>Brain Behav
          <year>2019</year>
<volume>9</volume>
<issue>6</issue>
<fpage>e01292</fpage>
<pub-id pub-id-type="doi">10.1002/brb3.1292</pub-id>
<pub-id pub-id-type="pmid">31033230</pub-id>
</element-citation>
</ref>
<ref id="CR60">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Louw</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Corveleyn</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Hens</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Gewillig</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Devriendt</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>MEIS2 involvement in cardiac development, cleft palate, and intellectual disability</article-title>
<source/>Am J Med Genet A
          <year>2015</year>
<volume>167A</volume>
<issue>5</issue>
<fpage>1142</fpage>
<lpage>1146</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.36989</pub-id>
<pub-id pub-id-type="pmid">25712757</pub-id>
</element-citation>
</ref>
<ref id="CR61">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Douglas</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Telegrafi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Winter</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Carmichael</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zackai</surname>
<given-names>EH</given-names>
</name>
<name>
<surname>Deardorff</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Harr</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Psychogios</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Erwin</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Grebe</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Retterer</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Juusola</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>De novo missense variants in MEIS2 recapitulate the microdeletion phenotype of cardiac and palate abnormalities, developmental delay, intellectual disability and dysmorphic features</article-title>
<source/>Am J Med Genet A
          <year>2018</year>
<volume>176</volume>
<issue>9</issue>
<fpage>1845</fpage>
<lpage>1851</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.40368</pub-id>
<pub-id pub-id-type="pmid">30055086</pub-id>
</element-citation>
</ref>
<ref id="CR62">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shimojima</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ondo</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Okamoto</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Yamamoto</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>A 15q14 microdeletion involving MEIS2 identified in a patient with autism spectrum disorder</article-title>
<source/>Hum Genome Var
          <year>2017</year>
<volume>4</volume>
<fpage>17029</fpage>
<pub-id pub-id-type="doi">10.1038/hgv.2017.29</pub-id>
<pub-id pub-id-type="pmid">28736618</pub-id>
</element-citation>
</ref>
<ref id="CR63">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Correia</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Cafe</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Almeida</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Mouga</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Oliveira</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Autism spectrum disorder: FRAXE mutation, a rare etiology</article-title>
<source/>J Autism Dev Disord
          <year>2015</year>
<volume>45</volume>
<issue>3</issue>
<fpage>888</fpage>
<lpage>892</lpage>
<pub-id pub-id-type="doi">10.1007/s10803-014-2185-8</pub-id>
<pub-id pub-id-type="pmid">25035088</pub-id>
</element-citation>
</ref>
<ref id="CR64">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sanchez-Sanchez</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Magdalon</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Griesi-Oliveira</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Yamamoto</surname>
<given-names>GL</given-names>
</name>
<name>
<surname>Santacruz-Perez</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Fogo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Passos-Bueno</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Sertie</surname>
<given-names>AL</given-names>
</name>
</person-group>
<article-title>Rare RELN variants affect Reelin-DAB1 signal transduction in autism spectrum disorder</article-title>
<source/>Hum Mutat
          <year>2018</year>
<volume>39</volume>
<issue>10</issue>
<fpage>1372</fpage>
<lpage>1383</lpage>
<pub-id pub-id-type="doi">10.1002/humu.23584</pub-id>
<pub-id pub-id-type="pmid">29969175</pub-id>
</element-citation>
</ref>
<ref id="CR65">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lammert</surname>
<given-names>DB</given-names>
</name>
<name>
<surname>Middleton</surname>
<given-names>FA</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Olson</surname>
<given-names>EC</given-names>
</name>
<name>
<surname>Howell</surname>
<given-names>BW</given-names>
</name>
</person-group>
<article-title>The de novo autism spectrum disorder RELN R2290C mutation reduces Reelin secretion and increases protein disulfide isomerase expression</article-title>
<source/>J Neurochem
          <year>2017</year>
<volume>142</volume>
<issue>1</issue>
<fpage>89</fpage>
<lpage>102</lpage>
<pub-id pub-id-type="doi">10.1111/jnc.14045</pub-id>
<pub-id pub-id-type="pmid">28419454</pub-id>
</element-citation>
</ref>
<ref id="CR66">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lammert</surname>
<given-names>DB</given-names>
</name>
<name>
<surname>Howell</surname>
<given-names>BW</given-names>
</name>
</person-group>
<article-title>RELN mutations in autism spectrum disorder</article-title>
<source/>Front Cell Neurosci
          <year>2016</year>
<volume>10</volume>
<fpage>84</fpage>
<pub-id pub-id-type="doi">10.3389/fncel.2016.00084</pub-id>
<pub-id pub-id-type="pmid">27064498</pub-id>
</element-citation>
</ref>
<ref id="CR67">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zou</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Lou</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ke</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Miao</surname>
<given-names>X</given-names>
</name>
</person-group>
<article-title>Reelin gene variants and risk of autism spectrum disorders: an integrated meta-analysis</article-title>
<source/>Am J Med Genet B Neuropsychiatr Genet
          <year>2014</year>
<volume>165B</volume>
<issue>2</issue>
<fpage>192</fpage>
<lpage>200</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.b.32222</pub-id>
<pub-id pub-id-type="pmid">24453138</pub-id>
</element-citation>
</ref>
<ref id="CR68">
<label>68.</label>
<mixed-citation publication-type="other">Bartnik M, Chun-Hui Tsai A, Xia Z, Cheung SW, Stankiewicz P: Disruption of the SCN2A and SCN3A genes in a patient with mental retardation, neurobehavioral and psychiatric abnormalities, and a history of infantile seizures. Clin Genet 2010.</mixed-citation>
</ref>
<ref id="CR69">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weiss</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Escayg</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kearney</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Trudeau</surname>
<given-names>M</given-names>
</name>
<name>
<surname>MacDonald</surname>
<given-names>BT</given-names>
</name>
<name>
<surname>Mori</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Reichert</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Buxbaum</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Meisler</surname>
<given-names>MH</given-names>
</name>
</person-group>
<article-title>Sodium channels SCN1A, SCN2A and SCN3A in familial autism</article-title>
<source/>Mol Psychiatry
          <year>2003</year>
<volume>8</volume>
<issue>2</issue>
<fpage>186</fpage>
<lpage>194</lpage>
<pub-id pub-id-type="doi">10.1038/sj.mp.4001241</pub-id>
<pub-id pub-id-type="pmid">12610651</pub-id>
</element-citation>
</ref>
<ref id="CR70">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname>
<given-names>YH</given-names>
</name>
<name>
<surname>Yuen</surname>
<given-names>RK</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Ju</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Mei</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>He</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Carter</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Chrysler</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Drmic</surname>
<given-names>IE</given-names>
</name>
<name>
<surname>Howe</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Lau</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Marshall</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Merico</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Nalpathamkalam</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Thiruvahindrapuram</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Uddin</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Anagnostou</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Zwaigenbaum</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Ring</surname>
<given-names>RH</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lajonchere</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Shih</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Szatmari</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Dawson</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Scherer</surname>
<given-names>SW</given-names>
</name>
</person-group>
<article-title>Detection of clinically relevant genetic variants in autism spectrum disorder by whole-genome sequencing</article-title>
<source/>Am J Hum Genet
          <year>2013</year>
<volume>93</volume>
<issue>2</issue>
<fpage>249</fpage>
<lpage>263</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2013.06.012</pub-id>
<pub-id pub-id-type="pmid">23849776</pub-id>
</element-citation>
</ref>
<ref id="CR71">
<label>71.</label>
<mixed-citation publication-type="other">Callaghan DB, Rogic S, Tan PPC, Calli K, Qiao Y, Baldwin R, Jacobson M, Belmadani M, Holmes N, Yu C, Li Y, Li Y, Kurtzke FE, Kuzeljevic B, Yu AY, Hudson M, Mcaughton AJM, Xu Y, Dionne-Laporte A, Girard S, Liang P, Separovic ER, Liu X, Rouleau G, Pavlidis P, Lewis MES: Whole genome sequencing and variant discovery in the ASPIRE autism spectrum disorder cohort. Clin Genet 2019.</mixed-citation>
</ref>
<ref id="CR72">
<label>72.</label>
<mixed-citation publication-type="other">Spratt PWE, Ben-Shalom R, Keeshen CM, Burke KJ,Jr, Clarkson RL, Sanders SJ, Bender KJ: The autism-associated gene Scn2a contributes to dendritic excitability and synaptic function in the prefrontal cortex. Neuron 2019.</mixed-citation>
</ref>
<ref id="CR73">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deneault</surname>
<given-names>E</given-names>
</name>
<name>
<surname>White</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Rodrigues</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>Ross</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Faheem</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Zaslavsky</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Alexandrova</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Pellecchia</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Piekna</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kaur</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Howe</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Kwan</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Thiruvahindrapuram</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Walker</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lionel</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Pasceri</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Merico</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Yuen</surname>
<given-names>RKC</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>KK</given-names>
</name>
<name>
<surname>Ellis</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Scherer</surname>
<given-names>SW</given-names>
</name>
</person-group>
<article-title>Complete disruption of autism-susceptibility genes by gene editing predominantly reduces functional connectivity of isogenic human neurons</article-title>
<source/>Stem Cell Reports
          <year>2018</year>
<volume>11</volume>
<issue>5</issue>
<fpage>1211</fpage>
<lpage>1225</lpage>
<pub-id pub-id-type="doi">10.1016/j.stemcr.2018.10.003</pub-id>
<pub-id pub-id-type="pmid">30392976</pub-id>
</element-citation>
</ref>
<ref id="CR74">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sanders</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Campbell</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Cottrell</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Moller</surname>
<given-names>RS</given-names>
</name>
<name>
<surname>Wagner</surname>
<given-names>FF</given-names>
</name>
<name>
<surname>Auldridge</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Bernier</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Catterall</surname>
<given-names>WA</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>WK</given-names>
</name>
<name>
<surname>Empfield</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>George</surname>
<given-names>AL</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Hipp</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Khwaja</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Kiskinis</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Lal</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Malhotra</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Millichap</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Otis</surname>
<given-names>TS</given-names>
</name>
<name>
<surname>Petrou</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Pitt</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Schust</surname>
<given-names>LF</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Tjernagel</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Spiro</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Bender</surname>
<given-names>KJ</given-names>
</name>
</person-group>
<article-title>Progress in understanding and treating SCN2A-mediated disorders</article-title>
<source/>Trends Neurosci
          <year>2018</year>
<volume>41</volume>
<issue>7</issue>
<fpage>442</fpage>
<lpage>456</lpage>
<pub-id pub-id-type="doi">10.1016/j.tins.2018.03.011</pub-id>
<pub-id pub-id-type="pmid">29691040</pub-id>
</element-citation>
</ref>
<ref id="CR75">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mondal</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ramachandran</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>VC</given-names>
</name>
<name>
<surname>Hagen</surname>
<given-names>KR</given-names>
</name>
<name>
<surname>Bose</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Cutler</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Zwick</surname>
<given-names>ME</given-names>
</name>
</person-group>
<article-title>Excess variants in AFF2 detected by massively parallel sequencing of males with autism spectrum disorder</article-title>
<source/>Hum Mol Genet
          <year>2012</year>
<volume>21</volume>
<issue>19</issue>
<fpage>4356</fpage>
<lpage>4364</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/dds267</pub-id>
<pub-id pub-id-type="pmid">22773736</pub-id>
</element-citation>
</ref>
<ref id="CR76">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sahoo</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Theisen</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Marble</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tervo</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Rosenfeld</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Torchia</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Shaffer</surname>
<given-names>LG</given-names>
</name>
</person-group>
<article-title>Microdeletion of Xq28 involving the AFF2 (FMR2) gene in two unrelated males with developmental delay</article-title>
<source/>Am J Med Genet A
          <year>2011</year>
<volume>155A</volume>
<issue>12</issue>
<fpage>3110</fpage>
<lpage>3115</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.34345</pub-id>
<pub-id pub-id-type="pmid">22065534</pub-id>
</element-citation>
</ref>
<ref id="CR77">
<label>77.</label>
<mixed-citation publication-type="other">Griswold AJ, Ma D, Cukier HN, Nations LD, Schmidt MA, Chung RH, Jaworski JM, Salyakina D, Konidari I, Whitehead PL, Wright HH, Abramson RK, Williams SM, Menon R, Martin ER, Haines JL, Gilbert JR, Cuccaro ML, Pericak-Vance MA: Evaluation of copy number variations reveals novel candidate genes in autism spectrum disorder-associated pathways. Hum Mol Genet 2012.</mixed-citation>
</ref>
<ref id="CR78">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname>
<given-names>EN</given-names>
</name>
<name>
<surname>Bloss</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Badner</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Barrett</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Belmonte</surname>
<given-names>PL</given-names>
</name>
<name>
<surname>Berrettini</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Byerley</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Coryell</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Craig</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Edenberg</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Eskin</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Foroud</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Gershon</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Greenwood</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Hipolito</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Koller</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Lawson</surname>
<given-names>WB</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Lohoff</surname>
<given-names>F</given-names>
</name>
<name>
<surname>MG</surname>
<given-names>MI</given-names>
</name>
<name>
<surname>FJ</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Mirel</surname>
<given-names>DB</given-names>
</name>
<name>
<surname>Murray</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Nievergelt</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Nurnberger</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Nwulia</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Paschall</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Potash</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Rice</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Schulze</surname>
<given-names>TG</given-names>
</name>
<name>
<surname>Scheftner</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Panganiban</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Zaitlen</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Zandi</surname>
<given-names>PP</given-names>
</name>
<name>
<surname>Zollner</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Schork</surname>
<given-names>NJ</given-names>
</name>
<name>
<surname>Kelsoe</surname>
<given-names>JR</given-names>
</name>
</person-group>
<article-title>Genome-wide association study of bipolar disorder in European American and African American individuals</article-title>
<source/>Mol Psychiatry
          <year>2009</year>
<volume>14</volume>
<issue>8</issue>
<fpage>755</fpage>
<lpage>763</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2009.43</pub-id>
<pub-id pub-id-type="pmid">19488044</pub-id>
</element-citation>
</ref>
<ref id="CR79">
<label>79.</label>
<mixed-citation publication-type="other">Mak ASL, Chiu ATG, Leung GKC, Mak CCY, Chu YWY, Mok GTK, Tang WF, Chan KYK, Tang MHY, Lau Yim ET, So KW, Tao VQ, Fung CW, Wong VCN, Uddin M, Lee SL, Marshall CR, Scherer SW, Kan ASY, Chung BHY: Use of clinical chromosomal microarray in Chinese patients with autism spectrum disorder-implications of a copy number variation involving DPP10. Mol Autism 2017, 8<bold>;</bold>31 doi: 10.1186/s13229-017-0136-x. eCollection 2017.</mixed-citation>
</ref>
<ref id="CR80">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Djurovic</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gustafsson</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Mattingsdal</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Athanasiu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Bjella</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Tesli</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Agartz</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Lorentzen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Melle</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Morken</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Andreassen</surname>
<given-names>OA</given-names>
</name>
</person-group>
<article-title>A genome-wide association study of bipolar disorder in Norwegian individuals, followed by replication in Icelandic sample</article-title>
<source/>J Affect Disord
          <year>2010</year>
<volume>126</volume>
<issue>1-2</issue>
<fpage>312</fpage>
<lpage>316</lpage>
<pub-id pub-id-type="doi">10.1016/j.jad.2010.04.007</pub-id>
<pub-id pub-id-type="pmid">20451256</pub-id>
</element-citation>
</ref>
<ref id="CR81">
<label>81.</label>
<mixed-citation publication-type="other">Verheije R, Kupchik GS, Isidor B, Kroes HY, Lynch SA, Hawkes L, Hempel M, Gelb BD, Ghoumid J, D’Amours G, Chandler K, Dubourg C, Loddo S, Tumer Z, Shaw-Smith C, Nizon M, Shevell M, Van Hoof E, Anyane-Yeboa K, Cerbone G, Clayton-Smith J, Cogne B, Corre P, Corveleyn A, De Borre M, Hjortshoj TD, Fradin M, Gewillig M, Goldmuntz E, Hens G, Lemyre E, Journel H, Kini U, Kortum F, Le Caignec C, Novelli A, Odent S, Petit F, Revah-Politi A, Stong N, Strom TM, van Binsbergen E, DDD study, Devriendt K, Breckpot J: Heterozygous loss-of-function variants of MEIS2 cause a triad of palatal defects, congenital heart defects, and intellectual disability. Eur J Hum Genet 2018.</mixed-citation>
</ref>
<ref id="CR82">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schreml</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Durmaz</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Cogulu</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Keupp</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Beleggia</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Pohl</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Milz</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Coker</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ucar</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Nurnberg</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Nurnberg</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Kuhn</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ozkinay</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>The missing "link": an autosomal recessive short stature syndrome caused by a hypofunctional XYLT1 mutation</article-title>
<source/>Hum Genet
          <year>2014</year>
<volume>133</volume>
<issue>1</issue>
<fpage>29</fpage>
<lpage>39</lpage>
<pub-id pub-id-type="doi">10.1007/s00439-013-1351-y</pub-id>
<pub-id pub-id-type="pmid">23982343</pub-id>
</element-citation>
</ref>
<ref id="CR83">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lopez-Hernandez</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Ridder</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Montolio</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Capdevila-Nortes</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Polder</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Sirisi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Duarri</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Schulte</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Fakler</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Nunes</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Scheper</surname>
<given-names>GC</given-names>
</name>
<name>
<surname>Martinez</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Estevez</surname>
<given-names>R</given-names>
</name>
<name>
<surname>van der Knaap</surname>
<given-names>MS</given-names>
</name>
</person-group>
<article-title>Mutant GlialCAM causes megalencephalic leukoencephalopathy with subcortical cysts, benign familial macrocephaly, and macrocephaly with retardation and autism</article-title>
<source/>Am J Hum Genet
          <year>2011</year>
<volume>88</volume>
<issue>4</issue>
<fpage>422</fpage>
<lpage>432</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2011.02.009</pub-id>
<pub-id pub-id-type="pmid">21419380</pub-id>
</element-citation>
</ref>
<ref id="CR84">
<label>84.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hamilton</surname>
<given-names>EMC</given-names>
</name>
<name>
<surname>Tekturk</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Cialdella</surname>
<given-names>F</given-names>
</name>
<name>
<surname>van Rappard</surname>
<given-names>DF</given-names>
</name>
<name>
<surname>Wolf</surname>
<given-names>NI</given-names>
</name>
<name>
<surname>Yalcinkaya</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Cetincelik</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Rajaee</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kariminejad</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Paprocka</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yapici</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Bosnjak</surname>
<given-names>VM</given-names>
</name>
<name>
<surname>van der Knaap</surname>
<given-names>MS</given-names>
</name>
</person-group>
<article-title>MLC research group: megalencephalic leukoencephalopathy with subcortical cysts: characterization of disease variants</article-title>
<source/>Neurology
          <year>2018</year>
<volume>90</volume>
<issue>16</issue>
<fpage>e1395</fpage>
<lpage>e1403</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.0000000000005334</pub-id>
<pub-id pub-id-type="pmid">29661901</pub-id>
</element-citation>
</ref>
<ref id="CR85">
<label>85.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Turkmen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Garshasbi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hoffmann</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Alshalah</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Mischung</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Kuss</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Humphrey</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Mundlos</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Robinson</surname>
<given-names>PN</given-names>
</name>
</person-group>
<article-title>CA8 mutations cause a novel syndrome characterized by ataxia and mild mental retardation with predisposition to quadrupedal gait</article-title>
<source/>PLoS Genet
          <year>2009</year>
<volume>5</volume>
<issue>5</issue>
<fpage>e1000487</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1000487</pub-id>
<pub-id pub-id-type="pmid">19461874</pub-id>
</element-citation>
</ref>
<ref id="CR86">
<label>86.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lam</surname>
<given-names>WW</given-names>
</name>
<name>
<surname>Millichap</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Soares</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>Chin</surname>
<given-names>R</given-names>
</name>
<name>
<surname>McLellan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>FitzPatrick</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Elmslie</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Lees</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Schaefer</surname>
<given-names>GB</given-names>
</name>
</person-group>
<article-title>DDD study, Abbott CM: novel de novo EEF1A2 missense mutations causing epilepsy and intellectual disability</article-title>
<source/>Mol Genet Genomic Med
          <year>2016</year>
<volume>4</volume>
<issue>4</issue>
<fpage>465</fpage>
<lpage>474</lpage>
<pub-id pub-id-type="doi">10.1002/mgg3.219</pub-id>
<pub-id pub-id-type="pmid">27441201</pub-id>
</element-citation>
</ref>
<ref id="CR87">
<label>87.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nakajima</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Okamoto</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Tohyama</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kato</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Arai</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Funahashi</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Tsurusaki</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Nakashima</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kawashima</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Saitsu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Matsumoto</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Miyake</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>De novo EEF1A2 mutations in patients with characteristic facial features, intellectual disability, autistic behaviors and epilepsy</article-title>
<source/>Clin Genet
          <year>2015</year>
<volume>87</volume>
<issue>4</issue>
<fpage>356</fpage>
<lpage>361</lpage>
<pub-id pub-id-type="doi">10.1111/cge.12394</pub-id>
<pub-id pub-id-type="pmid">24697219</pub-id>
</element-citation>
</ref>
<ref id="CR88">
<label>88.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mackay</surname>
<given-names>DS</given-names>
</name>
<name>
<surname>Bennett</surname>
<given-names>TM</given-names>
</name>
<name>
<surname>Shiels</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Exome sequencing identifies a missense variant in EFEMP1 co-segregating in a family with autosomal dominant primary open-angle glaucoma</article-title>
<source/>PLoS One
          <year>2015</year>
<volume>10</volume>
<issue>7</issue>
<fpage>e0132529</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0132529</pub-id>
<pub-id pub-id-type="pmid">26162006</pub-id>
</element-citation>
</ref>
<ref id="CR89">
<label>89.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>He</surname>
<given-names>X</given-names>
</name>
</person-group>
<article-title>Screening of candidate genes for primary open angle glaucoma</article-title>
<source/>Mol Vis
          <year>2012</year>
<volume>18</volume>
<fpage>2119</fpage>
<lpage>2126</lpage>
<pub-id pub-id-type="pmid">22876139</pub-id>
</element-citation>
</ref>
<ref id="CR90">
<label>90.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Springelkamp</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Mishra</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hysi</surname>
<given-names>PG</given-names>
</name>
<name>
<surname>Gharahkhani</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Hohn</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Khor</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Cooke Bailey</surname>
<given-names>JN</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Ramdas</surname>
<given-names>WD</given-names>
</name>
<name>
<surname>Vithana</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Koh</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Yazar</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Forward</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kearns</surname>
<given-names>LS</given-names>
</name>
<name>
<surname>Amin</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Iglesias</surname>
<given-names>AI</given-names>
</name>
<name>
<surname>Sim</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>van Leeuwen</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Demirkan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>van der Lee</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Loon</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Rivadeneira</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Nag</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sanfilippo</surname>
<given-names>PG</given-names>
</name>
<name>
<surname>Schillert</surname>
<given-names>A</given-names>
</name>
<name>
<surname>de Jong</surname>
<given-names>PT</given-names>
</name>
<name>
<surname>Oostra</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Uitterlinden</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Hofman</surname>
<given-names>A</given-names>
</name>
<collab>NEIGHBORHOOD Consortium</collab>
<name>
<surname>Zhou</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Burdon</surname>
<given-names>KP</given-names>
</name>
<name>
<surname>Spector</surname>
<given-names>TD</given-names>
</name>
<name>
<surname>Lackner</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Saw</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Vingerling</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Teo</surname>
<given-names>YY</given-names>
</name>
<name>
<surname>Pasquale</surname>
<given-names>LR</given-names>
</name>
<name>
<surname>Wolfs</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Lemij</surname>
<given-names>HG</given-names>
</name>
<name>
<surname>Tai</surname>
<given-names>ES</given-names>
</name>
<name>
<surname>Jonas</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>CY</given-names>
</name>
<name>
<surname>Aung</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Jansonius</surname>
<given-names>NM</given-names>
</name>
<name>
<surname>Klaver</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Craig</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>TL</given-names>
</name>
<name>
<surname>Haines</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>MacGregor</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Mackey</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Pfeiffer</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>TY</given-names>
</name>
<name>
<surname>Wiggs</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Hewitt</surname>
<given-names>AW</given-names>
</name>
<name>
<surname>van Duijn</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Hammond</surname>
<given-names>CJ</given-names>
</name>
</person-group>
<article-title>Meta-analysis of genome-wide association studies identifies novel loci associated with optic disc morphology</article-title>
<source/>Genet Epidemiol
          <year>2015</year>
<volume>39</volume>
<issue>3</issue>
<fpage>207</fpage>
<lpage>216</lpage>
<pub-id pub-id-type="doi">10.1002/gepi.21886</pub-id>
<pub-id pub-id-type="pmid">25631615</pub-id>
</element-citation>
</ref>
<ref id="CR91">
<label>91.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cusumano</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Falsini</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Giardina</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Cascella</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Sebastiani</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Marshall</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Doyne honeycomb retinal dystrophy - functional improvement following subthreshold nanopulse laser treatment: a case report</article-title>
<source/>J Med Case Rep
          <year>2019</year>
<volume>13</volume>
<issue>1</issue>
<fpage>5</fpage>
<pub-id pub-id-type="doi">10.1186/s13256-018-1935-1</pub-id>
<pub-id pub-id-type="pmid">30626431</pub-id>
</element-citation>
</ref>
<ref id="CR92">
<label>92.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Doyne honeycomb retinal dystrophy/malattia leventinese induced by EFEMP1 mutation in a Chinese family</article-title>
<source/>BMC Ophthalmol
          <year>2018</year>
<volume>18</volume>
<issue>1</issue>
<fpage>318</fpage>
<pub-id pub-id-type="doi">10.1186/s12886-018-0988-7</pub-id>
<pub-id pub-id-type="pmid">30541486</pub-id>
</element-citation>
</ref>
<ref id="CR93">
<label>93.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marmorstein</surname>
<given-names>LY</given-names>
</name>
<name>
<surname>Munier</surname>
<given-names>FL</given-names>
</name>
<name>
<surname>Arsenijevic</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Schorderet</surname>
<given-names>DF</given-names>
</name>
<name>
<surname>McLaughlin</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Traboulsi</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Marmorstein</surname>
<given-names>AD</given-names>
</name>
</person-group>
<article-title>Aberrant accumulation of EFEMP1 underlies drusen formation in Malattia Leventinese and age-related macular degeneration</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2002</year>
<volume>99</volume>
<issue>20</issue>
<fpage>13067</fpage>
<lpage>13072</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.202491599</pub-id>
<pub-id pub-id-type="pmid">12242346</pub-id>
</element-citation>
</ref>
<ref id="CR94">
<label>94.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hulleman</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Kelly</surname>
<given-names>JW</given-names>
</name>
</person-group>
<article-title>Genetic ablation of N-linked glycosylation reveals two key folding pathways for R345W fibulin-3, a secreted protein associated with retinal degeneration</article-title>
<source/>FASEB J
          <year>2015</year>
<volume>29</volume>
<issue>2</issue>
<fpage>565</fpage>
<lpage>575</lpage>
<pub-id pub-id-type="doi">10.1096/fj.14-255414</pub-id>
<pub-id pub-id-type="pmid">25389134</pub-id>
</element-citation>
</ref>
<ref id="CR95">
<label>95.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Balestri</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Crisafulli</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Donato</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Giegling</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Calati</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Antypa</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Schneider</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Marusic</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Tarozzi</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Marusic</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Paragi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hartmann</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Konte</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Marsano</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Serretti</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rujescu</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Nine differentially expressed genes from a post mortem study and their association with suicidal status in a sample of suicide completers, attempters and controls</article-title>
<source/>J Psychiatr Res
          <year>2017</year>
<volume>91</volume>
<fpage>98</fpage>
<lpage>104</lpage>
<pub-id pub-id-type="doi">10.1016/j.jpsychires.2017.03.009</pub-id>
<pub-id pub-id-type="pmid">28327445</pub-id>
</element-citation>
</ref>
<ref id="CR96">
<label>96.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Calati</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Giegling</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Balestri</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Antypa</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Friedl</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Konte</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Hartmann</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Serretti</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rujescu</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Influence of differentially expressed genes from suicide post-mortem study on personality traits as endophenotypes on healthy subjects and suicide attempters</article-title>
<source/>Eur Arch Psychiatry Clin Neurosci
          <year>2014</year>
<volume>264</volume>
<issue>5</issue>
<fpage>423</fpage>
<lpage>432</lpage>
<pub-id pub-id-type="doi">10.1007/s00406-013-0469-1</pub-id>
<pub-id pub-id-type="pmid">24241531</pub-id>
</element-citation>
</ref>
<ref id="CR97">
<label>97.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sokolowski</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wasserman</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wasserman</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Polygenic associations of neurodevelopmental genes in suicide attempt</article-title>
<source/>Mol Psychiatry
          <year>2016</year>
<volume>21</volume>
<issue>10</issue>
<fpage>1381</fpage>
<lpage>1390</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2015.187</pub-id>
<pub-id pub-id-type="pmid">26666204</pub-id>
</element-citation>
</ref>
<ref id="CR98">
<label>98.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thalmeier</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Dickmann</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Giegling</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Schneider</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Hartmann</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Maurer</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Schnabel</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kauert</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Moller</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Rujescu</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Gene expression profiling of post-mortem orbitofrontal cortex in violent suicide victims</article-title>
<source/>Int J Neuropsychopharmacol
          <year>2008</year>
<volume>11</volume>
<issue>2</issue>
<fpage>217</fpage>
<lpage>228</lpage>
<pub-id pub-id-type="doi">10.1017/S1461145707007894</pub-id>
<pub-id pub-id-type="pmid">17608962</pub-id>
</element-citation>
</ref>
<ref id="CR99">
<label>99.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Antosova</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Smolikova</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Klimova</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Lachova</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bendova</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kozmikova</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Machon</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Kozmik</surname>
<given-names>Z</given-names>
</name>
</person-group>
<article-title>The gene regulatory network of lens induction is wired through Meis-dependent shadow enhancers of Pax6</article-title>
<source/>PLoS Genet
          <year>2016</year>
<volume>12</volume>
<issue>12</issue>
<fpage>e1006441</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1006441</pub-id>
<pub-id pub-id-type="pmid">27918583</pub-id>
</element-citation>
</ref>
<ref id="CR100">
<label>100.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Conte</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Carrella</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Avellino</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Karali</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Marco-Ferreres</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Bovolenta</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Banfi S: miR-204 is required for lens and retinal development via Meis2 targeting</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2010</year>
<volume>107</volume>
<issue>35</issue>
<fpage>15491</fpage>
<lpage>15496</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0914785107</pub-id>
<pub-id pub-id-type="pmid">20713703</pub-id>
</element-citation>
</ref>
<ref id="CR101">
<label>101.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Pei</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Expression of lens-related microRNAs in transparent infant lenses and congenital cataract</article-title>
<source/>Int J Ophthalmol
          <year>2017</year>
<volume>10</volume>
<issue>3</issue>
<fpage>361</fpage>
<lpage>365</lpage>
<pub-id pub-id-type="pmid">28393025</pub-id>
</element-citation>
</ref>
<ref id="CR102">
<label>102.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heine</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Dohle</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Bumsted-O'Brien</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Engelkamp</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Schulte</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Evidence for an evolutionary conserved role of homothorax/Meis1/2 during vertebrate retina development</article-title>
<source/>Development
          <year>2008</year>
<volume>135</volume>
<issue>5</issue>
<fpage>805</fpage>
<lpage>811</lpage>
<pub-id pub-id-type="doi">10.1242/dev.012088</pub-id>
<pub-id pub-id-type="pmid">18216174</pub-id>
</element-citation>
</ref>
<ref id="CR103">
<label>103.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shiga</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Akiyama</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nishiguchi</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Shimozawa</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Momozawa</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Hirata</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Matsuda</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Yamaji</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Iwasaki</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tsugane</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Oze</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Mikami</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Naito</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wakai</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Yoshikawa</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Miyake</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yamashiro</surname>
<given-names>K</given-names>
</name>
<collab>Japan Glaucoma Society Omics Group (JGS-OG)</collab>
<name>
<surname>Kashiwagi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Iwata</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Mabuchi</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Takamoto</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ozaki</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kawase</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Aihara</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Araie</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yamamoto</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kiuchi</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ikeda</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Sonoda</surname>
<given-names>KH</given-names>
</name>
<name>
<surname>Ishibashi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Nitta</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Iwase</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Shirato</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Oka</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Satoh</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sasaki</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Fuse</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>CY</given-names>
</name>
<name>
<surname>Khor</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Baskaran</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Perera</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Aung</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Vithana</surname>
<given-names>EN</given-names>
</name>
<name>
<surname>Cooke Bailey</surname>
<given-names>JN</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Pasquale</surname>
<given-names>LR</given-names>
</name>
<name>
<surname>Haines</surname>
<given-names>JL</given-names>
</name>
<collab>NEIGHBORHOOD Consortium</collab>
<name>
<surname>Wiggs</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Burdon</surname>
<given-names>KP</given-names>
</name>
<name>
<surname>Gharahkhani</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Hewitt</surname>
<given-names>AW</given-names>
</name>
<name>
<surname>Mackey</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>MacGregor</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Craig</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Allingham</surname>
<given-names>RR</given-names>
</name>
<name>
<surname>Hauser</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ashaye</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Budenz</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Akafo</surname>
<given-names>S</given-names>
</name>
<name>
<surname>SEI</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Kamatani</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Nakazawa</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kubo</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Genome-wide association study identifies seven novel susceptibility loci for primary open-angle glaucoma</article-title>
<source/>Hum Mol Genet
          <year>2018</year>
<volume>27</volume>
<issue>8</issue>
<fpage>1486</fpage>
<lpage>1496</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddy053</pub-id>
<pub-id pub-id-type="pmid">29452408</pub-id>
</element-citation>
</ref>
<ref id="CR104">
<label>104.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gambin</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Bi</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Rosenfeld</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Coban-Akdemir</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Pursley</surname>
<given-names>AN</given-names>
</name>
<name>
<surname>SCS</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Marom</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Golla</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dengle</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Petrie</surname>
<given-names>HG</given-names>
</name>
<name>
<surname>Matalon</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Emrick</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Proud</surname>
<given-names>MB</given-names>
</name>
<name>
<surname>Treadwell-Deering</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Chao</surname>
<given-names>HT</given-names>
</name>
<name>
<surname>Koillinen</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Urraca</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Mostafavi</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Bernes</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Roeder</surname>
<given-names>ER</given-names>
</name>
<name>
<surname>Nugent</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Bader</surname>
<given-names>PI</given-names>
</name>
<name>
<surname>Bellus</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Cummings</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Northrup</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ashfaq</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Westman</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Wildin</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Beck</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Immken</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Elton</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Varghese</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Buchanan</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Faivre</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Lefebvre</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Schaaf</surname>
<given-names>CP</given-names>
</name>
<name>
<surname>Walkiewicz</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Lalani</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Bacino</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Beaudet</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Breman</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Cheung</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Lupski</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Shaw</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Stankiewicz</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Identification of novel candidate disease genes from de novo exonic copy number variants</article-title>
<source/>Genome Med
          <year>2017</year>
<volume>9</volume>
<issue>1</issue>
<fpage>83</fpage>
<pub-id pub-id-type="doi">10.1186/s13073-017-0472-7</pub-id>
<pub-id pub-id-type="pmid">28934986</pub-id>
</element-citation>
</ref>
<ref id="CR105">
<label>105.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Tao</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Pei</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Mao</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z</given-names>
</name>
</person-group>
<article-title>APOE influences working memory in non-demented elderly through an interaction with SPON1 rs2618516</article-title>
<source/>Hum Brain Mapp
          <year>2018</year>
<volume>39</volume>
<issue>7</issue>
<fpage>2859</fpage>
<lpage>2867</lpage>
<pub-id pub-id-type="doi">10.1002/hbm.24045</pub-id>
<pub-id pub-id-type="pmid">29573041</pub-id>
</element-citation>
</ref>
<ref id="CR106">
<label>106.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Senormanci</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Karakas Celik</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Valipour</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Dogan</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Senormanci</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Determination of candidate genes involved in schizophrenia using the whole-exome sequencing</article-title>
<source/>Bratisl Lek Listy
          <year>2018</year>
<volume>119</volume>
<issue>9</issue>
<fpage>572</fpage>
<lpage>576</lpage>
<pub-id pub-id-type="pmid">30226068</pub-id>
</element-citation>
</ref>
<ref id="CR107">
<label>107.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sherva</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Tripodis</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Bennett</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Chibnik</surname>
<given-names>LB</given-names>
</name>
<name>
<surname>Crane</surname>
<given-names>PK</given-names>
</name>
<name>
<surname>de Jager</surname>
<given-names>PL</given-names>
</name>
<name>
<surname>Farrer</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Saykin</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Shulman</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Naj</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>RC</given-names>
</name>
<collab>GENAROAD Consortium</collab>
</person-group>
<article-title>Alzheimer's disease neuroimaging initiative, Alzheimer's disease genetics consortium: genome-wide association study of the rate of cognitive decline in Alzheimer's disease</article-title>
<source/>Alzheimers Dement
          <year>2014</year>
<volume>10</volume>
<issue>1</issue>
<fpage>45</fpage>
<lpage>52</lpage>
<pub-id pub-id-type="doi">10.1016/j.jalz.2013.01.008</pub-id>
<pub-id pub-id-type="pmid">23535033</pub-id>
</element-citation>
</ref>
<ref id="CR108">
<label>108.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jahanshad</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Rajagopalan</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Hua</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Hibar</surname>
<given-names>DP</given-names>
</name>
<name>
<surname>Nir</surname>
<given-names>TM</given-names>
</name>
<name>
<surname>Toga</surname>
<given-names>AW</given-names>
</name>
<name>
<surname>Jack</surname>
<given-names>CR</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Saykin</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Weiner</surname>
<given-names>MW</given-names>
</name>
<name>
<surname>Medland</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Montgomery</surname>
<given-names>GW</given-names>
</name>
<name>
<surname>Hansell</surname>
<given-names>NK</given-names>
</name>
<name>
<surname>McMahon</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>de Zubicaray</surname>
<given-names>GI</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>NG</given-names>
</name>
<name>
<surname>Wright</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>PM</given-names>
</name>
</person-group>
<article-title>Alzheimer's disease neuroimaging initiative: genome-wide scan of healthy human connectome discovers SPON1 gene variant influencing dementia severity</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2013</year>
<volume>110</volume>
<issue>12</issue>
<fpage>4768</fpage>
<lpage>4773</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1216206110</pub-id>
<pub-id pub-id-type="pmid">23471985</pub-id>
</element-citation>
</ref>
<ref id="CR109">
<label>109.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wolf</surname>
<given-names>LV</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Braunger</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Tamm</surname>
<given-names>ER</given-names>
</name>
<name>
<surname>Zavadil</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Cvekl</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Identification of pax6-dependent gene regulatory networks in the mouse lens</article-title>
<source/>PLoS One
          <year>2009</year>
<volume>4</volume>
<issue>1</issue>
<fpage>e4159</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0004159</pub-id>
<pub-id pub-id-type="pmid">19132093</pub-id>
</element-citation>
</ref>
<ref id="CR110">
<label>110.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fernandez-Godino</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Garland</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Pierce</surname>
<given-names>EA</given-names>
</name>
</person-group>
<article-title>A local complement response by RPE causes early-stage macular degeneration</article-title>
<source/>Hum Mol Genet
          <year>2015</year>
<volume>24</volume>
<issue>19</issue>
<fpage>5555</fpage>
<lpage>5569</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddv287</pub-id>
<pub-id pub-id-type="pmid">26199322</pub-id>
</element-citation>
</ref>
<ref id="CR111">
<label>111.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Protas</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Weh</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Footz</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kasberger</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Baraban</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Levin</surname>
<given-names>AV</given-names>
</name>
<name>
<surname>Katz</surname>
<given-names>LJ</given-names>
</name>
<name>
<surname>Ritch</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Walter</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Semina</surname>
<given-names>EV</given-names>
</name>
<name>
<surname>Gould</surname>
<given-names>DB</given-names>
</name>
</person-group>
<article-title>Mutations of conserved non-coding elements of PITX2 in patients with ocular dysgenesis and developmental glaucoma</article-title>
<source/>Hum Mol Genet
          <year>2017</year>
<volume>26</volume>
<issue>18</issue>
<fpage>3630</fpage>
<lpage>3638</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddx251</pub-id>
<pub-id pub-id-type="pmid">28911203</pub-id>
</element-citation>
</ref>
<ref id="CR112">
<label>112.</label>
<mixed-citation publication-type="other">Moazzeni H, Mirrahimi M, Moghadam A, Banaei-Esfahani A, Yazdani S, Elahi E: Identification of genes involved in glaucoma pathogenesis using combined network analysis and empirical studies. Hum Mol Genet 2019.</mixed-citation>
</ref>
<ref id="CR113">
<label>113.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Souzeau</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Siggs</surname>
<given-names>OM</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Galanopoulos</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hodson</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Taranath</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Mills</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Landers</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Pater</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Elder</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Rait</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Giles</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Phakey</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Staffieri</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Kearns</surname>
<given-names>LS</given-names>
</name>
<name>
<surname>Dubowsky</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mackey</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Hewitt</surname>
<given-names>AW</given-names>
</name>
<name>
<surname>Ruddle</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Burdon</surname>
<given-names>KP</given-names>
</name>
<name>
<surname>Craig</surname>
<given-names>JE</given-names>
</name>
</person-group>
<article-title>Glaucoma spectrum and age-related prevalence of individuals with FOXC1 and PITX2 variants</article-title>
<source/>Eur J Hum Genet
          <year>2017</year>
<volume>25</volume>
<issue>11</issue>
<fpage>1290</fpage>
<pub-id pub-id-type="doi">10.1038/ejhg.2017.147</pub-id>
<pub-id pub-id-type="pmid">29023440</pub-id>
</element-citation>
</ref>
<ref id="CR114">
<label>114.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bockenhauer</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Bokenkamp</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Nuutinen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Unwin</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Van't Hoff</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Sirimanna</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Vrljicak</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Ludwig</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Novel OCRL mutations in patients with Dent-2 disease</article-title>
<source/>J Pediatr Genet
          <year>2012</year>
<volume>1</volume>
<issue>1</issue>
<fpage>15</fpage>
<lpage>23</lpage>
<pub-id pub-id-type="doi">10.3233/PGE-2012-005</pub-id>
<pub-id pub-id-type="pmid">27625797</pub-id>
</element-citation>
</ref>
<ref id="CR115">
<label>115.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Montjean</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Aoidi</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Desbois</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Rucci</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Trichet</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Salomon</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Rendu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Faure</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lunardi</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gacon</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Billuart</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Dorseuil</surname>
<given-names>O</given-names>
</name>
</person-group>
<article-title>OCRL-mutated fibroblasts from patients with Dent-2 disease exhibit INPP5B-independent phenotypic variability relatively to Lowe syndrome cells</article-title>
<source/>Hum Mol Genet
          <year>2015</year>
<volume>24</volume>
<issue>4</issue>
<fpage>994</fpage>
<lpage>1006</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddu514</pub-id>
<pub-id pub-id-type="pmid">25305077</pub-id>
</element-citation>
</ref>
<ref id="CR116">
<label>116.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hichri</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Rendu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Monnier</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Coutton</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Dorseuil</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Poussou</surname>
<given-names>RV</given-names>
</name>
<name>
<surname>Baujat</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Blanchard</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Nobili</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Ranchin</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Remesy</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Salomon</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Satre</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Lunardi</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>From Lowe syndrome to Dent disease: correlations between mutations of the OCRL1 gene and clinical and biochemical phenotypes</article-title>
<source/>Hum Mutat
          <year>2011</year>
<volume>32</volume>
<issue>4</issue>
<fpage>379</fpage>
<lpage>388</lpage>
<pub-id pub-id-type="doi">10.1002/humu.21391</pub-id>
<pub-id pub-id-type="pmid">21031565</pub-id>
</element-citation>
</ref>
<ref id="CR117">
<label>117.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Recker</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Zaniew</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bockenhauer</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Miglietti</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Bokenkamp</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Moczulska</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rogowska-Kalisz</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Laube</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Said-Conti</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Kasap-Demir</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Niemirska</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Litwin</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Siten</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Chrzanowska</surname>
<given-names>KH</given-names>
</name>
<name>
<surname>Krajewska-Walasek</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sethi</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Tasic</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Anglani</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Addis</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wasilewska</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Szczepanska</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pawlaczyk</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Sikora</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Ludwig</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Characterization of 28 novel patients expands the mutational and phenotypic spectrum of Lowe syndrome</article-title>
<source/>Pediatr Nephrol
          <year>2015</year>
<volume>30</volume>
<issue>6</issue>
<fpage>931</fpage>
<lpage>943</lpage>
<pub-id pub-id-type="doi">10.1007/s00467-014-3013-2</pub-id>
<pub-id pub-id-type="pmid">25480730</pub-id>
</element-citation>
</ref>
<ref id="CR118">
<label>118.</label>
<mixed-citation publication-type="other">Law CW, Chen Y, Shi W, Smyth GK: Voom: precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol 2014, 15(2)<bold>;</bold>doi: 10.1186/gb-2014-15-2-r29.</mixed-citation>
</ref>
<ref id="CR119">
<label>119.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sanchez-Pulido</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Ponting</surname>
<given-names>CP</given-names>
</name>
</person-group>
<article-title>TMEM132: an ancient architecture of cohesin and immunoglobulin domains define a new family of neural adhesion molecules</article-title>
<source/>Bioinformatics
          <year>2018</year>
<volume>34</volume>
<issue>5</issue>
<fpage>721</fpage>
<lpage>724</lpage>
<pub-id pub-id-type="doi">10.1093/bioinformatics/btx689</pub-id>
<pub-id pub-id-type="pmid">29088312</pub-id>
</element-citation>
</ref>
<ref id="CR120">
<label>120.</label>
<mixed-citation publication-type="other">Chen B, Chou HT, Brautigam CA, Xing W, Yang S, Henry L, Doolittle LK, Walz T, Rosen MK. Rac1 GTPase activates the WAVE regulatory complex through two distinct binding sites. Elife. 2017;6. 10.7554/eLife.29795.</mixed-citation>
</ref>
<ref id="CR121">
<label>121.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carreras</surname>
<given-names>FJ</given-names>
</name>
</person-group>
<article-title>Lessons from glaucoma: rethinking the fluid-brain barriers in common neurodegenerative disorders</article-title>
<source/>Neural Regen Res
          <year>2019</year>
<volume>14</volume>
<issue>6</issue>
<fpage>962</fpage>
<lpage>966</lpage>
<pub-id pub-id-type="doi">10.4103/1673-5374.249215</pub-id>
<pub-id pub-id-type="pmid">30762000</pub-id>
</element-citation>
</ref>
<ref id="CR122">
<label>122.</label>
<mixed-citation publication-type="other">Alqawlaq S, Flanagan JG, Sivak JM: All roads lead to glaucoma: Induced retinal injury cascades contribute to a common neurodegenerative outcome. Exp Eye Res 2018.</mixed-citation>
</ref>
<ref id="CR123">
<label>123.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Targeting the complement system for the management of retinal inflammatory and degenerative diseases</article-title>
<source/>Eur J Pharmacol
          <year>2016</year>
<volume>787</volume>
<fpage>94</fpage>
<lpage>104</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejphar.2016.03.001</pub-id>
<pub-id pub-id-type="pmid">26948311</pub-id>
</element-citation>
</ref>
<ref id="CR124">
<label>124.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Camaj</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Seeliger</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ischenko</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Krebs</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Blum</surname>
<given-names>H</given-names>
</name>
<name>
<surname>De Toni</surname>
<given-names>EN</given-names>
</name>
<name>
<surname>Faktorova</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Jauch</surname>
<given-names>KW</given-names>
</name>
<name>
<surname>Bruns</surname>
<given-names>CJ</given-names>
</name>
</person-group>
<article-title>EFEMP1 binds the EGF receptor and activates MAPK and Akt pathways in pancreatic carcinoma cells</article-title>
<source/>Biol Chem
          <year>2009</year>
<volume>390</volume>
<issue>12</issue>
<fpage>1293</fpage>
<lpage>1302</lpage>
<pub-id pub-id-type="doi">10.1515/BC.2009.140</pub-id>
<pub-id pub-id-type="pmid">19804359</pub-id>
</element-citation>
</ref>
<ref id="CR125">
<label>125.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fuchshofer</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Stephan</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Russell</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Tamm</surname>
<given-names>ER</given-names>
</name>
</person-group>
<article-title>Gene expression profiling of TGFbeta2- and/or BMP7-treated trabecular meshwork3cells: identification of Smad7 as a critical inhibitor of TGF-beta2 signaling</article-title>
<source/>Exp Eye Res
          <year>2009</year>
<volume>88</volume>
<issue>6</issue>
<fpage>1020</fpage>
<lpage>1032</lpage>
<pub-id pub-id-type="doi">10.1016/j.exer.2009.01.002</pub-id>
<pub-id pub-id-type="pmid">19450457</pub-id>
</element-citation>
</ref>
<ref id="CR126">
<label>126.</label>
<mixed-citation publication-type="other">Shrestha R, Wen YT, Ding DC, Tsai RK. Aberrant hiPSCs-derived from human keratinocytes differentiates into 3D retinal organoids that acquire mature photoreceptors. Cells. 2019;8(1). 10.3390/cells8010036.</mixed-citation>
</ref>
<ref id="CR127">
<label>127.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Jain</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gramlich</surname>
<given-names>OW</given-names>
</name>
<name>
<surname>Tucker</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Sheffield</surname>
<given-names>VC</given-names>
</name>
<name>
<surname>Kuehn</surname>
<given-names>MH</given-names>
</name>
</person-group>
<article-title>Restoration of aqueous humor outflow following transplantation of iPSC-derived trabecular meshwork cells in a transgenic mouse model of glaucoma</article-title>
<source/>Invest Ophthalmol Vis Sci
          <year>2017</year>
<volume>58</volume>
<issue>4</issue>
<fpage>2054</fpage>
<lpage>2062</lpage>
<pub-id pub-id-type="doi">10.1167/iovs.16-20672</pub-id>
<pub-id pub-id-type="pmid">28384726</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>